{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:20:39Z","timestamp":1792462839393,"version":"4.5.0"},"reference-count":419,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T00:00:00Z","timestamp":1470096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T00:00:00Z","timestamp":1470096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/npp.2016.143","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T07:02:11Z","timestamp":1470121331000},"page":"216-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":445,"title":["Inflammation Effects on Motivation and Motor Activity: Role of Dopamine"],"prefix":"10.1038","volume":"42","author":[{"given":"Jennifer C","family":"Felger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T","family":"Treadway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,2]]},"reference":[{"key":"BFnpp2016143_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","volume":"67","author":"M aan het Rot","year":"2010","unstructured":"aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS et al (2010). Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry 67: 139\u2013145.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1176\/ajp.155.11.1550","volume":"155","author":"A Abi-Dargham","year":"1998","unstructured":"Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M et al (1998). Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 155: 761\u2013767.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1200\/JCO.2002.20.2.485","volume":"20","author":"TA Ahles","year":"2002","unstructured":"Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K et al (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20: 485\u2013493.","journal-title":"J Clin Oncol"},{"key":"BFnpp2016143_CR4","first-page":"12","volume":"16","author":"J Ananth","year":"1991","unstructured":"Ananth J, Djenderdjian A, Shamasunder P, Costa J, Herrera J, Sramek J (1991). Negative symptoms: psychopathological models. J Psychiatry Neurosci 16: 12\u201318.","journal-title":"J Psychiatry Neurosci"},{"key":"BFnpp2016143_CR5","first-page":"1280","volume":"6","author":"G Arrondo","year":"2015","unstructured":"Arrondo G, Segarra N, Metastasio A, Ziauddeen H, Spencer J, Reinders NR et al (2015). Reduction in ventral striatal activity when anticipating a reward in depression and schizophrenia: a replicated cross-diagnostic finding. Fron Psychol 6: 1280.","journal-title":"Fron Psychol"},{"key":"BFnpp2016143_CR6","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/schbul\/sbs087","volume":"38","author":"M Bamne","year":"2012","unstructured":"Bamne M, Wood J, Chowdari K, Watson AM, Celik C, Mansour H et al (2012). Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure. Schizophr Bull 38: 1149\u20131154.","journal-title":"Schizophr Bull"},{"key":"BFnpp2016143_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nbd.2009.07.031","volume":"37","author":"WA Banks","year":"2010","unstructured":"Banks WA, Erickson MA (2010). The blood-brain barrier and immune function and dysfunction. Neurobiol Dis 37: 26\u201332.","journal-title":"Neurobiol Dis"},{"key":"BFnpp2016143_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000071472","volume":"10","author":"WA Banks","year":"2002","unstructured":"Banks WA, Farr SA, Morley JE (2002). Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes. Neuroimmunomodulation 10: 319\u2013327.","journal-title":"Neuroimmunomodulation"},{"key":"BFnpp2016143_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000097202","volume":"2","author":"WA Banks","year":"1995","unstructured":"Banks WA, Kastin AJ, Broadwell RD (1995). Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2: 241\u2013248.","journal-title":"Neuroimmunomodulation"},{"key":"BFnpp2016143_CR10","doi-asserted-by":"publisher","first-page":"360481","DOI":"10.1155\/2014\/360481","volume":"2014","author":"IG Barbosa","year":"2014","unstructured":"Barbosa IG, Bauer ME, Machado-Vieira R, Teixeira AL (2014). Cytokines in bipolar disorder: paving the way for neuroprogression. Neural Plast 2014: 360481.","journal-title":"Neural Plast"},{"key":"BFnpp2016143_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1037\/a0036299","volume":"123","author":"DM Barch","year":"2014","unstructured":"Barch DM, Treadway MT, Schoen N (2014). Effort, anhedonia, and function in schizophrenia: Reduced effort allocation predicts amotivation and functional impairment. J Abnorm Psychol 123: 387.","journal-title":"J Abnorm Psychol"},{"key":"BFnpp2016143_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1046\/j.1460-9568.2000.00996.x","volume":"12","author":"M Barrot","year":"2000","unstructured":"Barrot M, Marinelli M, Abrous DN, Rouge-Pont F, Le Moal M, Piazza PV (2000). The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur J Neurosci 12: 973\u2013979.","journal-title":"Eur J Neurosci"},{"key":"BFnpp2016143_CR13","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/sj.bjp.0702940","volume":"128","author":"WM Behan","year":"1999","unstructured":"Behan WM, McDonald M, Darlington LG, Stone TW (1999). Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br J Pharmacol 128: 1754\u20131760.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2016143_CR14","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/npp.2013.48","volume":"38","author":"U Beierholm","year":"2013","unstructured":"Beierholm U, Guitart-Masip M, Economides M, Chowdhury R, Duzel E, Dolan R et al (2013). Dopamine modulates reward-related vigor. Neuropsychopharmacology 38: 1495\u20131503.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR15","doi-asserted-by":"publisher","first-page":"158746","DOI":"10.1155\/2013\/158746","volume":"2013","author":"D Bennabi","year":"2013","unstructured":"Bennabi D, Vandel P, Papaxanthis C, Pozzo T, Haffen E (2013). Psychomotor retardation in depression: a systematic review of diagnostic, pathophysiologic, and therapeutic implications. Biomed Res Int 2013: 158746.","journal-title":"Biomed Res Int"},{"key":"BFnpp2016143_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1741-7015-11-200","volume":"11","author":"M Berk","year":"2013","unstructured":"Berk M, Williams LJ, Jacka FN, O'Neil A, Pasco JA, Moylan S et al (2013). So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11: 200.","journal-title":"BMC Med"},{"key":"BFnpp2016143_CR17","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1176\/appi.ajp.2013.12070978","volume":"170","author":"J Bernacer","year":"2013","unstructured":"Bernacer J, Corlett PR, Ramachandra P, McFarlane B, Turner DC, Clark L et al (2013). Methamphetamine-induced disruption of frontostriatal reward learning signals: relation to psychotic symptoms. Am J Psychiatry 170: 1326\u20131334.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973). Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations. J Neurol Sci 20: 415\u2013455.","journal-title":"J Neurol Sci"},{"key":"BFnpp2016143_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00213-006-0578-x","volume":"191","author":"KC Berridge","year":"2007","unstructured":"Berridge KC (2007). The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl) 191: 391\u2013431.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2016143_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00213-008-1099-6","volume":"199","author":"KC Berridge","year":"2008","unstructured":"Berridge KC, Kringelbach ML (2008). Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology (Berl) 199: 457\u2013480.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2016143_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.conb.2013.01.017","volume":"23","author":"KC Berridge","year":"2013","unstructured":"Berridge KC, Kringelbach ML (2013). Neuroscience of affect: brain mechanisms of pleasure and displeasure. Curr Opin Neurobiol 23: 294\u2013303.","journal-title":"Curr Opin Neurobiol"},{"key":"BFnpp2016143_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/npp.2013.232","volume":"39","author":"JM Bjork","year":"2014","unstructured":"Bjork JM, Grant SJ, Chen G, Hommer DW (2014). Dietary tyrosine\/phenylalanine depletion effects on behavioral and brain signatures of human motivational processing. Neuropsychopharmacology 39: 595\u2013604.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/0006-291X(81)91284-5","volume":"101","author":"JE Blalock","year":"1981","unstructured":"Blalock JE, Smith EM (1981). Human leukocyte interferon (HuIFN-alpha): potent endorphin-like opioid activity. Biochem Biophys Res Commun 101: 472\u2013478.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFnpp2016143_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1176\/appi.ajp.2015.14101358","volume":"173","author":"PS Bloomfield","year":"2015","unstructured":"Bloomfield PS, Selvaraj S, Veronese M, Rizzo G, Bertoldo A, Owen DR et al (2015). Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [11C] PBR28 PET brain imaging study. Am J Psychiatry 173: 44\u201352.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR25","first-page":"499","volume":"317","author":"RM Bluthe","year":"1994","unstructured":"Bluthe RM, Walter V, Parnet P, Laye S, Lestage J, Verrier D et al (1994). Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C R Acad Sci III 317: 499\u2013503.","journal-title":"C R Acad Sci III"},{"key":"BFnpp2016143_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","volume":"22","author":"S Bonaccorso","year":"2002","unstructured":"Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M et al (2002). Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 22: 86\u201390.","journal-title":"J Clin Psychopharmacol"},{"key":"BFnpp2016143_CR27","doi-asserted-by":"publisher","first-page":"e0140678","DOI":"10.1371\/journal.pone.0140678","volume":"10","author":"DR Bonsall","year":"2015","unstructured":"Bonsall DR, Kim H, Tocci C, Ndiaye A, Petronzio A, McKay-Corkum G et al (2015). Suppression of locomotor activity in female C57Bl\/6J mice treated with interleukin-1beta: investigating a method for the study of fatigue in laboratory animals. PLoS One 10: e0140678.","journal-title":"PLoS One"},{"key":"BFnpp2016143_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/mp.2010.38","volume":"16","author":"FJ Bosker","year":"2011","unstructured":"Bosker FJ, Hartman CA, Nolte IM, Prins BP, Terpstra P, Posthuma D et al (2011). Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry 16: 516\u2013532.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016143_CR29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/00006842-200207000-00010","volume":"64","author":"JE Bower","year":"2002","unstructured":"Bower JE, Ganz PA, Aziz N, Fahey JL (2002). Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64: 604\u2013611.","journal-title":"Psychosom Med"},{"key":"BFnpp2016143_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.pscychresns.2006.07.002","volume":"154","author":"V Bragulat","year":"2007","unstructured":"Bragulat V, Paillere-Martinot ML, Artiges E, Frouin V, Poline JB, Martinot JL (2007). Dopaminergic function in depressed patients with affective flattening or with impulsivity: [18F]fluoro-L-dopa positron emission tomography study with voxel-based analysis. Psychiatry Res 154: 115\u2013124.","journal-title":"Psychiatry Res"},{"key":"BFnpp2016143_CR31","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1038\/tp.2014.46","volume":"4","author":"P Brambilla","year":"2014","unstructured":"Brambilla P, Bellani M, Isola M, Bergami A, Marinelli V, Dusi N et al (2014). Increased M1\/decreased M2 signature and signs of Th1\/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia. Transl Psychiatry 4: e406.","journal-title":"Transl Psychiatry"},{"key":"BFnpp2016143_CR32","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1200\/JCO.2012.45.3696","volume":"31","author":"E Bruera","year":"2013","unstructured":"Bruera E, Yennurajalingam S, Palmer JL, Perez-Cruz PE, Frisbee-Hume S, Allo JA et al (2013). Methylphenidate and\/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. J Clin Oncol 31: 2421\u20132427.","journal-title":"J Clin Oncol"},{"key":"BFnpp2016143_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nri1369","volume":"4","author":"PA Bryant","year":"2004","unstructured":"Bryant PA, Trinder J, Curtis N (2004). Sick and tired: Does sleep have a vital role in the immune system? Nat Rev Immunol 4: 457\u2013467.","journal-title":"Nat Rev Immunol"},{"key":"BFnpp2016143_CR34","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.biopsych.2007.12.007","volume":"63","author":"L Brydon","year":"2008","unstructured":"Brydon L, Harrison NA, Walker C, Steptoe A, Critchley HD (2008). Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry 63: 1022\u20131029.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbi.2012.04.009","volume":"31","author":"C Bufalino","year":"2012","unstructured":"Bufalino C, Hepgul N, Aguglia E, Pariante CM (2012). The role of immune genes in the association between depression and inflammation: A review of recent clinical studies. Brain Behav Immun 31: 31\u201347.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2016143_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ymgme.2010.06.015","volume":"101","author":"BK Burton","year":"2010","unstructured":"Burton BK, Bausell H, Katz R, Laduca H, Sullivan C (2010). Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU). Mol Genet Metab 101: 110\u2013114.","journal-title":"Mol Genet Metab"},{"key":"BFnpp2016143_CR37","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.ijrobp.2007.05.076","volume":"69","author":"JM Butler Jr.","year":"2007","unstructured":"Butler JM Jr., Case LD, Atkins J, Frizzell B, Sanders G, Griffin P et al (2007). A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys 69: 1496\u20131501.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFnpp2016143_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.pnpbp.2010.10.019","volume":"35","author":"JS Buyukdura","year":"2011","unstructured":"Buyukdura JS, McClintock SM, Croarkin PE (2011). Psychomotor retardation in depression: biological underpinnings, measurement, and treatment. Prog Neuropsychopharmacol Biol Psychiatry 35: 395\u2013409.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp2016143_CR39","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cpr.2007.10.001","volume":"28","author":"LM Bylsma","year":"2008","unstructured":"Bylsma LM, Morris BH, Rottenberg J (2008). A meta-analysis of emotional reactivity in major depressive disorder. Clin Psychol Rev 28: 676\u2013691.","journal-title":"Clin Psychol Rev"},{"key":"BFnpp2016143_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.nurt.2007.04.006","volume":"4","author":"A Cagnin","year":"2007","unstructured":"Cagnin A, Kassiou M, Meikle SR, Banati RB (2007). Positron emission tomography imaging of neuroinflammation. Neurotherapeutics 4: 443\u2013452.","journal-title":"Neurotherapeutics"},{"key":"BFnpp2016143_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0165-0327(99)00068-3","volume":"57","author":"MP Caligiuri","year":"2000","unstructured":"Caligiuri MP, Ellwanger J (2000). Motor and cognitive aspects of motor retardation in depression. J Affect Disord 57: 83\u201393.","journal-title":"J Affect Disord"},{"key":"BFnpp2016143_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0378-4347(94)80070-7","volume":"657","author":"M Candito","year":"1994","unstructured":"Candito M, Nagatsu T, Chambon P, Chatel M (1994). High-performance liquid chromatographic measurement of cerebrospinal fluid tetrahydrobiopterin, neopterin, homovanillic acid and 5-hydroxindoleacetic acid in neurological diseases. J Chromatogr B Biomed Appl 657: 61\u201366.","journal-title":"J Chromatogr B Biomed Appl"},{"key":"BFnpp2016143_CR43","doi-asserted-by":"publisher","first-page":"10827","DOI":"10.1523\/JNEUROSCI.23-34-10827.2003","volume":"23","author":"CM Cannon","year":"2003","unstructured":"Cannon CM, Palmiter RD (2003). Reward without dopamine. J Neurosci 23: 10827\u201310831.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR44","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/npp.2008.194","volume":"34","author":"DM Cannon","year":"2009","unstructured":"Cannon DM, Klaver JM, Peck SA, Rallis-Voak D, Erickson K, Drevets WC (2009). Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112. Neuropsychopharmacology 34: 1277\u20131287.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR45","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","volume":"26","author":"L Capuron","year":"2002","unstructured":"Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB et al (2002a). Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26: 643\u2013652.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR46","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0889-1591(02)00007-7","volume":"16","author":"L Capuron","year":"2002","unstructured":"Capuron L, Hauser P, Hinze-Selch D, Miller AH, Neveu PJ (2002b). Treatment of cytokine-induced depression. Brain Behav Immun 16: 575\u2013580.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2016143_CR47","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.biopsych.2004.02.009","volume":"56","author":"L Capuron","year":"2004","unstructured":"Capuron L, Miller AH (2004). Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 56: 819\u2013824.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR48","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","volume":"54","author":"L Capuron","year":"2003","unstructured":"Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D et al (2003a). Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry 54: 906\u2013914.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR49","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1038\/sj.npp.1301362","volume":"32","author":"L Capuron","year":"2007","unstructured":"Capuron L, Pagnoni G, Demetrashvili MF, Lawson DH, Fornwalt FB, Woolwine B et al (2007). Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology 32: 2384\u20132392.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR50","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/archgenpsychiatry.2011.2094","volume":"69","author":"L Capuron","year":"2012","unstructured":"Capuron L, Pagnoni G, Drake DF, Woolwine BJ, Spivey JR, Crowe RJ et al (2012). Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch Gen Psychiatry 69: 1044\u20131053.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2016143_CR51","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1176\/appi.ajp.160.7.1342","volume":"160","author":"L Capuron","year":"2003","unstructured":"Capuron L, Raison CL, Musselman DL, Lawson DH, Nemeroff CB, Miller AH (2003b). Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry 160: 1342\u20131345.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR52","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.biopsych.2010.12.006","volume":"70","author":"L Capuron","year":"2011","unstructured":"Capuron L, Schroecksnadel S, Feart C, Aubert A, Higueret D, Barberger-Gateau P et al (2011). Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol Psychiatry 70: 175\u2013182.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/da.20038","volume":"20","author":"P Cassano","year":"2004","unstructured":"Cassano P, Lattanzi L, Soldani F, Navari S, Battistini G, Gemignani A et al (2004). Pramipexole in treatment-resistant depression: an extended follow-up. Depress Anxiety 20: 131\u2013138.","journal-title":"Depress Anxiety"},{"issue":"Suppl 2","key":"BFnpp2016143_CR54","first-page":"S157","volume":"25","author":"A Castro-Garcia","year":"1997","unstructured":"Castro-Garcia A (1997). [Psychiatric complications of L-dopa: physiopathology and treatment]. Rev Neurol 25 (Suppl 2): S157\u2013S162.","journal-title":"Rev Neurol"},{"key":"BFnpp2016143_CR55","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/npp.2012.191","volume":"38","author":"A Cattaneo","year":"2013","unstructured":"Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ et al (2013). Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. Neuropsychopharmacology 38: 377\u2013385.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR56","doi-asserted-by":"publisher","first-page":"8138","DOI":"10.1523\/JNEUROSCI.0319-07.2007","volume":"27","author":"WM Caudle","year":"2007","unstructured":"Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL et al (2007). Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci 27: 8138\u20138148.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR57","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.psychres.2014.11.007","volume":"225","author":"KA Chase","year":"2015","unstructured":"Chase KA, Rosen C, Gin H, Bjorkquist O, Feiner B, Marvin R et al (2015). Metabolic and inflammatory genes in schizophrenia. Psychiatry Res 225: 208\u2013211.","journal-title":"Psychiatry Res"},{"key":"BFnpp2016143_CR58","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nature11713","volume":"493","author":"D Chaudhury","year":"2013","unstructured":"Chaudhury D, Walsh JJ, Friedman AK, Juarez B, Ku SM, Koo JW et al (2013). Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 493: 532\u2013536.","journal-title":"Nature"},{"key":"BFnpp2016143_CR59","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1073\/pnas.98.4.1970","volume":"98","author":"JF Chen","year":"2001","unstructured":"Chen JF, Moratalla R, Impagnatiello F, Grandy DK, Cuellar B, Rubinstein M et al (2001). The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proc Natl Acad Sci USA 98: 1970\u20131975.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2016143_CR60","doi-asserted-by":"publisher","first-page":"e23178","DOI":"10.1371\/journal.pone.0023178","volume":"6","author":"ML Clery-Melin","year":"2011","unstructured":"Clery-Melin ML, Schmidt L, Lafargue G, Baup N, Fossati P, Pessiglione M (2011). Why don't you try harder? An investigation of effort production in major depression. PLoS ONE 6: e23178.","journal-title":"PLoS ONE"},{"key":"BFnpp2016143_CR61","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1744-8069-6-75","volume":"6","author":"U Coffeen","year":"2010","unstructured":"Coffeen U, Ortega-Legaspi JM, de Gortari P, Simon-Arceo K, Jaimes O, Amaya MI et al (2010). Inflammatory nociception diminishes dopamine release and increases dopamine D2 receptor mRNA in the rat's insular cortex. Mol Pain 6: 75.","journal-title":"Mol Pain"},{"key":"BFnpp2016143_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nn.4207","volume":"19","author":"AG Collins","year":"2016","unstructured":"Collins AG, Frank MJ (2016). Surprise! Dopamine signals mix action, value and error. Nat Neurosci 19: 3\u20135.","journal-title":"Nat Neurosci"},{"key":"BFnpp2016143_CR63","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.bbr.2010.03.003","volume":"211","author":"LE Collins","year":"2010","unstructured":"Collins LE, Galtieri DJ, Collins P, Jones SK, Port RG, Paul NE et al (2010). Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: effects on locomotor activity. Behav Brain Res 211: 148\u2013155.","journal-title":"Behav Brain Res"},{"key":"BFnpp2016143_CR64","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1027\/1614-0001.29.3.168","volume":"29","author":"AJ Cooper","year":"2008","unstructured":"Cooper AJ, Smillie LD, Jackson CJ (2008). A trait conceptualization of reward-reactivity. J Individ Differ 29: 168\u2013180.","journal-title":"J Individ Differ"},{"key":"BFnpp2016143_CR65","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0166-4328(02)00292-9","volume":"137","author":"M Correa","year":"2002","unstructured":"Correa M, Carlson BB, Wisniecki A, Salamone JD (2002). Nucleus accumbens dopamine and work requirements on interval schedules. Behav Brain Res 137: 179\u2013187.","journal-title":"Behav Brain Res"},{"key":"BFnpp2016143_CR66","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1136\/hrt.2009.180430","volume":"96","author":"C Cunnington","year":"2010","unstructured":"Cunnington C, Channon KM (2010). Tetrahydrobiopterin: pleiotropic roles in cardiovascular pathophysiology. Heart 96: 1872\u20131877.","journal-title":"Heart"},{"key":"BFnpp2016143_CR67","doi-asserted-by":"publisher","first-page":"e636","DOI":"10.4088\/JCP.12m08093","volume":"74","author":"C Cusin","year":"2013","unstructured":"Cusin C, Iovieno N, Iosifescu DV, Nierenberg AA, Fava M, Rush AJ et al (2013). A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. J Clin Psychiatry 74: e636\u2013e641.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2016143_CR68","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/S0028-3932(02)00108-2","volume":"40","author":"V Czernecki","year":"2002","unstructured":"Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B (2002). Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia 40: 2257\u20132267.","journal-title":"Neuropsychologia"},{"key":"BFnpp2016143_CR69","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1126\/science.1150605","volume":"5867","author":"KMS D\u2019Ardenne","year":"2008","unstructured":"D\u2019Ardenne KMS, Nystrom LE, Cohen JD (2008). BOLD responses reflecting dopaminergic signals in the human ventral tegmental area. Science 5867: 1264\u20131267.","journal-title":"Science"},{"key":"BFnpp2016143_CR70","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0006-3223(94)91202-5","volume":"35","author":"HA D'Haenen","year":"1994","unstructured":"D'Haenen HA, Bossuyt A (1994). Dopamine D2 receptors in depression measured with single photon emission computed tomography. Biol Psychiatry 35: 128\u2013132.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR71","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1523\/JNEUROSCI.3567-08.2009","volume":"29","author":"C D'Mello","year":"2009","unstructured":"D'Mello C, Le T, Swain MG (2009). Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J Neurosci 29: 2089\u20132102.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR72","doi-asserted-by":"publisher","first-page":"10821","DOI":"10.1523\/JNEUROSCI.0575-15.2015","volume":"35","author":"C D'Mello","year":"2015","unstructured":"D'Mello C, Ronaghan N, Zaheer R, Dicay M, Le T, MacNaughton WK et al (2015). Probiotics improve inflammation-associated sickness behavior by altering communication between the peripheral immune system and the brain. J Neurosci 35: 10821\u201310830.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR73","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/mp.2010.5","volume":"16","author":"A Danese","year":"2011","unstructured":"Danese A, Caspi A, Williams B, Ambler A, Sugden K, Mika J et al (2011). Biological embedding of stress through inflammation processes in childhood. Mol Psychiatry 16: 244\u2013246.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016143_CR74","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/archpsyc.65.4.409","volume":"65","author":"A Danese","year":"2008","unstructured":"Danese A, Moffitt TE, Pariante CM, Ambler A, Poulton R, Caspi A (2008). Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry 65: 409\u2013415.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2016143_CR75","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1073\/pnas.0610362104","volume":"104","author":"A Danese","year":"2007","unstructured":"Danese A, Pariante CM, Caspi A, Taylor A, Poulton R (2007). Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci USA 104: 1319\u20131324.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2016143_CR76","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","volume":"36","author":"R Dantzer","year":"2011","unstructured":"Dantzer R, O'Connor JC, Lawson MA, Kelley KW (2011). Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 36: 426\u2013436.","journal-title":"Psychoneuroendocrinology"},{"key":"BFnpp2016143_CR77","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00702-014-1187-1","volume":"121","author":"R Dantzer","year":"2014","unstructured":"Dantzer R, Walker AK (2014). Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? J Neural Transm (Vienna) 121: 925\u2013932.","journal-title":"J Neural Transm (Vienna)"},{"key":"BFnpp2016143_CR78","doi-asserted-by":"publisher","first-page":"G440","DOI":"10.1152\/ajpgi.00098.2010","volume":"299","author":"CB de La Serre","year":"2010","unstructured":"de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE (2010). Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 299: G440\u2013G448.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFnpp2016143_CR79","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0376-8716(86)90068-2","volume":"16","author":"H de Wit","year":"1986","unstructured":"de Wit H, Uhlenhuth EH, Johanson CE (1986). Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend 16: 341\u2013360.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2016143_CR80","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.biopsych.2009.06.021","volume":"66","author":"GS Dichter","year":"2009","unstructured":"Dichter GS, Felder JN, Petty C, Bizzell J, Ernst M, Smoski MJ (2009). The effects of psychotherapy on neural responses to rewards in major depression. Biol Psychiatry 66: 886\u2013897.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR81","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/da.20690","volume":"27","author":"GS Dichter","year":"2010","unstructured":"Dichter GS, Smoski MJ, Kampov-Polevoy AB, Gallop R, Garbutt JC (2010). Unipolar depression does not moderate responses to the Sweet Taste Test. Depression Anxiety 27: 859\u2013863.","journal-title":"Depression Anxiety"},{"key":"BFnpp2016143_CR82","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.neuropsychologia.2012.02.007","volume":"50","author":"EK Diekhof","year":"2012","unstructured":"Diekhof EK, Kaps L, Falkai P, Gruber O (2012). The role of the human ventral striatum and the medial orbitofrontal cortex in the representation of reward magnitude - an activation likelihood estimation meta-analysis of neuroimaging studies of passive reward expectancy and outcome processing. Neuropsychologia 50: 1252\u20131266.","journal-title":"Neuropsychologia"},{"key":"BFnpp2016143_CR83","first-page":"201","volume":"10","author":"CA Dinarello","year":"2004","unstructured":"Dinarello CA (2004). Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res 10: 201\u2013222.","journal-title":"J Endotoxin Res"},{"key":"BFnpp2016143_CR84","first-page":"166","volume":"178","author":"JA Dominic","year":"1969","unstructured":"Dominic JA, Moore KE (1969a). Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice. Arch Int Pharmacodyn Ther 178: 166\u2013176.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"BFnpp2016143_CR85","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/BF00407041","volume":"15","author":"JA Dominic","year":"1969","unstructured":"Dominic JA, Moore KE (1969b). Supersensitivity to the central stimulant actions of adrenergic drugs following discontinuation of a chronic diet of alpha-methyltyrosine. Psychopharmacologia 15: 96\u2013101.","journal-title":"Psychopharmacologia"},{"key":"BFnpp2016143_CR86","first-page":"921","volume":"25","author":"S Donnelly","year":"1998","unstructured":"Donnelly S (1998). Patient management strategies for interferon alfa-2b as adjuvant therapy of high-risk melanoma. Oncol Nurs Forum 25: 921\u2013927.","journal-title":"Oncol Nurs Forum"},{"key":"BFnpp2016143_CR87","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ymgme.2013.04.017","volume":"109","author":"TD Douglas","year":"2013","unstructured":"Douglas TD, Jinnah HA, Bernhard D, Singh RH (2013). The effects of sapropterin on urinary monoamine metabolites in phenylketonuria. Mol Genet Metab 109: 243\u2013250.","journal-title":"Mol Genet Metab"},{"key":"BFnpp2016143_CR88","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.biopsych.2015.05.015","volume":"79","author":"NG Dowell","year":"2016","unstructured":"Dowell NG, Cooper EA, Tibble J, Voon V, Critchley HD, Cercignani M et al (2016). Acute changes in striatal microstructure predict the development of interferon-alpha induced fatigue. Biol Psychiatry 79: 320\u2013328.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR89","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al (2010). A meta-analysis of cytokines in major depression. Biol Psychiatry 67: 446\u2013457.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR90","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jad.2015.03.032","volume":"179","author":"A Drago","year":"2015","unstructured":"Drago A, Crisafulli C, Calabro M, Serretti A (2015). Enrichment pathway analysis. The inflammatory genetic background in bipolar disorder. J Affect Disord 179: 88\u201394.","journal-title":"J Affect Disord"},{"key":"BFnpp2016143_CR91","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0006-3223(00)01038-6","volume":"49","author":"WC Drevets","year":"2001","unstructured":"Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA et al (2001). Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49: 81\u201396.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR92","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","volume":"64","author":"BW Dunlop","year":"2007","unstructured":"Dunlop BW, Nemeroff CB (2007). The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64: 327\u2013337.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2016143_CR93","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/jcbfm.1994.99","volume":"14","author":"D Eidelberg","year":"1994","unstructured":"Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T et al (1994). The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 14: 783\u2013801.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2016143_CR94","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.biopsych.2010.06.010","volume":"68","author":"NI Eisenberger","year":"2010","unstructured":"Eisenberger NI, Berkman ET, Inagaki TK, Rameson LT, Mashal NM, Irwin MR (2010). Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry 68: 748\u2013754.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR95","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1523\/JNEUROSCI.14-02-00897.1994","volume":"14","author":"A Ericsson","year":"1994","unstructured":"Ericsson A, Kovacs KJ, Sawchenko PE (1994). A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14: 897\u2013913.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR96","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/PPO.0000000000000018","volume":"20","author":"CP Escalante","year":"2014","unstructured":"Escalante CP, Meyers C, Reuben JM, Wang X, Qiao W, Manzullo E et al (2014). A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J 20: 8\u201314.","journal-title":"Cancer J"},{"issue":"Suppl 4","key":"BFnpp2016143_CR97","first-page":"40","volume":"60","author":"DL Evans","year":"1999","unstructured":"Evans DL, Staab JP, Petitto JM, Morrison MF, Szuba MP, Ward HE et al (1999). Depression in the medical setting: biopsychological interactions and treatment considerations. J Clin Psychiatry 60 (Suppl 4): 40\u201355.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2016143_CR98","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bbr.2007.05.005","volume":"182","author":"B Fahey","year":"2007","unstructured":"Fahey B, Hickey B, Kelleher D, O'Dwyer AM, O'Mara SM (2007). The widely-used anti-viral drug interferon-alpha induces depressive- and anxiogenic-like effects in healthy rats. Behav Brain Res 182: 80\u201387.","journal-title":"Behav Brain Res"},{"key":"BFnpp2016143_CR99","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1176\/ajp.154.12.1760","volume":"154","author":"M Fava","year":"1997","unstructured":"Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T (1997). Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry 154: 426\u2013428.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR100","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1176\/appi.ajp.2015.15060788","volume":"173","author":"J Fawcett","year":"2016","unstructured":"Fawcett J, Rush AJ, Vukelich J, Diaz SH, Dunklee L, Romo P et al (2016). Clinical experience with high-dosage pramipexole in patients with treatment-resistant depressive episodes in unipolar and bipolar depression. Am J Psychiatry 173: 107\u2013111.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR101","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archpsyc.1972.01750190059011","volume":"26","author":"JP Feighner","year":"1972","unstructured":"Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R (1972). Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26: 57\u201363.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2016143_CR102","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.biopsych.2007.05.026","volume":"62","author":"JC Felger","year":"2007","unstructured":"Felger JC, Alagbe O, Hu F, Mook D, Freeman AA, Sanchez MM et al (2007). Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry 62: 1324\u20131333.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyu084","volume":"18","author":"JC Felger","year":"2015","unstructured":"Felger JC, Hernandez CR, Miller AH (2015). Levodopa reverses cytokine-induced reductions in striatal dopamine release. Int J Neuropsychopharmacol 18: 1\u20135.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp2016143_CR104","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbi.2012.10.010","volume":"31","author":"JC Felger","year":"2013","unstructured":"Felger JC, Li L, Marvar PJ, Woolwine BJ, Harrison DG, Raison CL et al (2013a). Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations. Brain Behav Immun 31: 153\u2013160.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2016143_CR105","doi-asserted-by":"crossref","unstructured":"Felger JC, Li Z, Haroon E, Woolwine BJ, Jung MY, Hu X et al (2016). Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry (in press).","DOI":"10.1038\/mp.2015.168"},{"key":"BFnpp2016143_CR106","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","volume":"246","author":"JC Felger","year":"2013","unstructured":"Felger JC, Lotrich FE (2013b). Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications. Neuroscience 246: 199\u2013229.","journal-title":"Neuroscience"},{"key":"BFnpp2016143_CR107","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.yfrne.2012.09.003","volume":"33","author":"JC Felger","year":"2012","unstructured":"Felger JC, Miller AH (2012). Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol 33: 315\u2013327.","journal-title":"Front Neuroendocrinol"},{"key":"BFnpp2016143_CR108","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/npp.2013.115","volume":"38","author":"JC Felger","year":"2013","unstructured":"Felger JC, Mun J, Kimmel HL, Nye JA, Drake DF, Hernandez CR et al (2013c). Chronic interferon-alpha decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates. Neuropsychopharmacology 38: 2179\u20132187.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR109","doi-asserted-by":"publisher","first-page":"aac9698","DOI":"10.1126\/science.aac9698","volume":"351","author":"EA Ferenczi","year":"2016","unstructured":"Ferenczi EA, Zalocusky KA, Liston C, Grosenick L, Warden MR, Amatya D et al (2016). Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior. Science 351: aac9698.","journal-title":"Science"},{"key":"BFnpp2016143_CR110","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.neubiorev.2008.01.004","volume":"32","author":"MJ Ferris","year":"2008","unstructured":"Ferris MJ, Mactutus CF, Booze RM (2008). Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev 32: 883\u2013909.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2016143_CR111","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.jpsychires.2013.08.003","volume":"47","author":"G Fervaha","year":"2013","unstructured":"Fervaha G, Graff-Guerrero A, Zakzanis KK, Foussias G, Agid O, Remington G (2013). Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making. J Psychiatr Res 47: 1590\u20131596.","journal-title":"J Psychiatr Res"},{"key":"BFnpp2016143_CR112","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1038\/tp.2014.8","volume":"4","author":"SG Fillman","year":"2014","unstructured":"Fillman SG, Sinclair D, Fung SJ, Webster MJ, Shannon Weickert C (2014). Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Transl Psychiatry 4: e365.","journal-title":"Transl Psychiatry"},{"key":"BFnpp2016143_CR113","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1176\/appi.ajp.2008.07081336","volume":"166","author":"EE Forbes","year":"2009","unstructured":"Forbes EE, Hariri AR, Martin SL, Silk JS, Moyles DL, Fisher PM et al (2009). Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry 166: 64\u201373.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR114","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jad.2013.02.003","volume":"149","author":"JA Franco-Chaves","year":"2013","unstructured":"Franco-Chaves JA, Mateus CF, Luckenbaugh DA, Martinez PE, Mallinger AG, Zarate CA Jr. (2013). Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study. J Affect Disord 149: 319\u2013325.","journal-title":"J Affect Disord"},{"key":"BFnpp2016143_CR115","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1037\/0735-7044.120.3.497","volume":"120","author":"MJ Frank","year":"2006","unstructured":"Frank MJ, O'Reilly RC (2006). A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci 120: 497.","journal-title":"Behav Neurosci"},{"key":"BFnpp2016143_CR116","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1126\/science.1102941","volume":"306","author":"MJ Frank","year":"2004","unstructured":"Frank MJ, Seeberger LC, O'Reilly RC (2004). By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306: 1940\u20131943.","journal-title":"Science"},{"key":"BFnpp2016143_CR117","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.psyneuen.2007.03.005","volume":"32","author":"F Frenois","year":"2007","unstructured":"Frenois F, Moreau M, O'Connor J, Lawson M, Micon C, Lestage J et al (2007). Lipopolysaccharide induces delayed FosB\/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 32: 516\u2013531.","journal-title":"Psychoneuroendocrinology"},{"key":"BFnpp2016143_CR118","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/schbul\/sbr180","volume":"39","author":"P Fusar-Poli","year":"2012","unstructured":"Fusar-Poli P, Meyer-Lindenberg A (2012). Striatal presynaptic dopamine in schizophrenia, Part II: meta-analysis of [18F\/11C]-DOPA PET studies. Schizophr Bull 39: 33\u201342.","journal-title":"Schizophr Bull"},{"key":"BFnpp2016143_CR119","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jrp.2005.11.001","volume":"40","author":"DE Gard","year":"2006","unstructured":"Gard DE, Gard MG, Kring AM, John OP (2006). Anticipatory and consummatory components of the experience of pleasure: a scale development study. J Res Personality 40: 1086\u20131102.","journal-title":"J Res Personality"},{"key":"BFnpp2016143_CR120","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1037\/abn0000005","volume":"123","author":"DE Gard","year":"2014","unstructured":"Gard DE, Sanchez AH, Cooper K, Fisher M, Garrett C, Vinogradov S (2014). Do people with schizophrenia have difficulty anticipating pleasure, engaging in effortful behavior, or both? J Abnorm Psychol 123: 771\u2013782.","journal-title":"J Abnorm Psychol"},{"key":"BFnpp2016143_CR121","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/sj.npp.1300217","volume":"28","author":"DL Garver","year":"2003","unstructured":"Garver DL, Tamas RL, Holcomb JA (2003). Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype. Neuropsychopharmacology 28: 1515\u20131520.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR122","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11481-006-9030-6","volume":"1","author":"BB Gelman","year":"2006","unstructured":"Gelman BB, Spencer JA, Holzer CE 3rd, Soukup VM (2006). Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium subjects with HIV encephalitis. J Neuroimmune Pharmacol 1: 410\u2013420.","journal-title":"J Neuroimmune Pharmacol"},{"key":"BFnpp2016143_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/aje\/kwj347","volume":"165","author":"S Gilbody","year":"2007","unstructured":"Gilbody S, Lewis S, Lightfoot T (2007a). Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol 165: 1\u201313.","journal-title":"Am J Epidemiol"},{"key":"BFnpp2016143_CR124","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/jech.2006.050385","volume":"61","author":"S Gilbody","year":"2007","unstructured":"Gilbody S, Lightfoot T, Sheldon T (2007b). Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health 61: 631\u2013637.","journal-title":"J Epidemiol Community Health"},{"key":"BFnpp2016143_CR125","first-page":"19","volume":"8","author":"LD Ginsberg","year":"2011","unstructured":"Ginsberg LD, Oubre AY, Daoud YA (2011). L-methylfolate Plus SSRI or SNRI from treatment initiation compared to SSRI or SNRI monotherapy in a major depressive episode. Innov Clin Neurosci 8: 19\u201328.","journal-title":"Innov Clin Neurosci"},{"key":"BFnpp2016143_CR126","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/0140-6736(90)91942-4","volume":"336","author":"PS Godfrey","year":"1990","unstructured":"Godfrey PS, Toone BK, Carney MW, Flynn TG, Bottiglieri T, Laundy M et al (1990). Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336: 392\u2013395.","journal-title":"Lancet"},{"key":"BFnpp2016143_CR127","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.biopsych.2012.12.022","volume":"74","author":"JM Gold","year":"2013","unstructured":"Gold JM, Strauss GP, Waltz JA, Robinson BM, Brown JK, Frank MJ (2013). Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol Psychiatry 74: 130\u2013136.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR128","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/schbul\/sbn068","volume":"34","author":"JM Gold","year":"2008","unstructured":"Gold JM, Waltz JA, Prentice KJ, Morris SE, Heerey EA (2008). Reward processing in schizophrenia: a deficit in the representation of value. Schizophr Bull 34: 835\u2013847.","journal-title":"Schizophr Bull"},{"key":"BFnpp2016143_CR129","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bbi.2016.03.025","volume":"56","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Haroon E, Woolwine BJ, Jung MY, Wommack EC, Harvey PD et al (2016a). Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder. Brain Behav Immun 56: 281\u2013288.","journal-title":"Brain Behav Immun"},{"issue":"12","key":"BFnpp2016143_CR130","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"D R Goldsmith","year":"2016","unstructured":"Goldsmith DR, Rapaport MH, Miller BJ (2016b). A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry (in press).","journal-title":"Molecular Psychiatry"},{"key":"BFnpp2016143_CR131","doi-asserted-by":"publisher","first-page":"e84391","DOI":"10.1371\/journal.pone.0084391","volume":"9","author":"S Gong","year":"2014","unstructured":"Gong S, Sheng P, Jin H, He H, Qi E, Chen W et al (2014). Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis. PLoS One 9: e84391.","journal-title":"PLoS One"},{"key":"BFnpp2016143_CR132","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/archgenpsychiatry.2010.13","volume":"67","author":"IH Gotlib","year":"2010","unstructured":"Gotlib IH, Hamilton JP, Cooney RE, Singh MK, Henry ML, Joormann J (2010). Neural processing of reward and loss in girls at risk for major depression. Arch Gen Psychiatry 67: 380\u2013387.","journal-title":"Arch Gen Psychiatry"},{"issue":"Pt 6","key":"BFnpp2016143_CR133","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1093\/brain\/awr059","volume":"134","author":"VB Gradin","year":"2011","unstructured":"Gradin VB, Kumar P, Waiter G, Ahearn T, Stickle C, Milders M et al (2011). Expected value and prediction error abnormalities in depression and schizophrenia. Brain 134 (Pt 6): 1751\u20131764.","journal-title":"Brain"},{"key":"BFnpp2016143_CR134","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1176\/appi.ajp.2015.14050594","volume":"172","author":"T Greenberg","year":"2015","unstructured":"Greenberg T, Chase HW, Almeida JR, Stiffler R, Zevallos CR, Aslam HA et al (2015). Moderation of the relationship between reward expectancy and prediction error-related ventral striatal reactivity by anhedonia in unmedicated major depressive disorder: findings from the EMBARC study. Am J Psychiatry 172: 881\u2013891.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR135","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/j.1742-4658.2012.08493.x","volume":"279","author":"GJ Guillemin","year":"2012","unstructured":"Guillemin GJ (2012). Quinolinic acid: neurotoxicity. FEBS J 279: 1355.","journal-title":"FEBS J"},{"key":"BFnpp2016143_CR136","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/glia.10175","volume":"41","author":"GJ Guillemin","year":"2003","unstructured":"Guillemin GJ, Croitoru-Lamoury J, Dormont D, Armati PJ, Brew BJ (2003). Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes. Glia 41: 371\u2013381.","journal-title":"Glia"},{"key":"BFnpp2016143_CR137","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.npep.2008.04.003","volume":"42","author":"TS Guillot","year":"2008","unstructured":"Guillot TS, Richardson JR, Wang MZ, Li YJ, Taylor TN, Ciliax BJ et al (2008). PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. Neuropeptides 42: 423\u2013434.","journal-title":"Neuropeptides"},{"key":"BFnpp2016143_CR138","doi-asserted-by":"publisher","first-page":"17029","DOI":"10.1038\/srep17029","volume":"6","author":"J Guo","year":"2016","unstructured":"Guo J, Zhang W, Zhang L, Ding H, Zhang J, Song C et al (2016). Probable involvement of p11 with interferon alpha induced depression. Sci Rep 6: 17029.","journal-title":"Sci Rep"},{"key":"BFnpp2016143_CR139","first-page":"687469","volume":"2014","author":"S Guo","year":"2014","unstructured":"Guo S, Chen S, Zhang Q, Wang Y, Xu K, Zheng X (2014). Optogenetic activation of the excitatory neurons expressing CaMKIIalpha in the ventral tegmental area upregulates the locomotor activity of free behaving rats. Biomed Res Int 2014: 687469.","journal-title":"Biomed Res Int"},{"key":"BFnpp2016143_CR140","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2009.129","volume":"35","author":"SN Haber","year":"2010","unstructured":"Haber SN, Knutson B (2010). The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 35: 4\u201326.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR141","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nn.4173","volume":"19","author":"AA Hamid","year":"2016","unstructured":"Hamid AA, Pettibone JR, Mabrouk OS, Hetrick VL, Schmidt R, Vander Weele CM et al (2016). Mesolimbic dopamine signals the value of work. Nature neuroscience 19: 117\u2013126.","journal-title":"Nature neuroscience"},{"key":"BFnpp2016143_CR142","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/mp.2010.46","volume":"16","author":"JP Hamilton","year":"2011","unstructured":"Hamilton JP, Chen G, Thomason ME, Schwartz ME, Gotlib IH (2011). Investigating neural primacy in major depressive disorder: multivariate Granger causality analysis of resting-state fMRI time-series data. Mol Psychiatry 16: 763\u2013772.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016143_CR143","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neuroimage.2012.06.055","volume":"63","author":"J Hannestad","year":"2012","unstructured":"Hannestad J, Gallezot J-D, Schafbauer T, Lim K, Kloczynski T, Morris ED et al (2012a). Endotoxin-induced systemic inflammation activates microglia:[11 C] PBR28 positron emission tomography in nonhuman primates. Neuroimage 63: 232\u2013239.","journal-title":"Neuroimage"},{"key":"BFnpp2016143_CR144","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neuroimage.2012.06.055","volume":"63","author":"J Hannestad","year":"2012","unstructured":"Hannestad J, Gallezot JD, Schafbauer T, Lim K, Kloczynski T, Morris ED et al (2012b). Endotoxin-induced systemic inflammation activates microglia: [(11)C]PBR28 positron emission tomography in nonhuman primates. Neuroimage 63: 232\u2013239.","journal-title":"Neuroimage"},{"key":"BFnpp2016143_CR145","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nn835","volume":"5","author":"GE Hardingham","year":"2002","unstructured":"Hardingham GE, Fukunaga Y, Bading H (2002). Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 5: 405\u2013414.","journal-title":"Nat Neurosci"},{"key":"BFnpp2016143_CR146","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.1523\/JNEUROSCI.1309-08.2008","volume":"28","author":"TA Hare","year":"2008","unstructured":"Hare TA, O'Doherty J, Camerer CF, Schultz W, Rangel A (2008). Dissociating the role of the orbitofrontal cortex and the striatum in the computation of goal values and prediction errors. J Neurosci 28: 5623\u20135630.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR147","doi-asserted-by":"crossref","unstructured":"Haroon E, Fleischer CC, Felger JC, Chen X, Woolwine BJ, Patel T et al (2016). Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression. Mol Psychiatry (in press).","DOI":"10.1038\/mp.2015.206"},{"key":"BFnpp2016143_CR148","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/npp.2011.205","volume":"37","author":"E Haroon","year":"2012","unstructured":"Haroon E, Raison CL, Miller AH (2012). Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37: 137\u2013162.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR149","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/npp.2014.222","volume":"40","author":"NA Harrison","year":"2015","unstructured":"Harrison NA, Cercignani M, Voon V, Critchley HD (2015a). Effects of inflammation on hippocampus and substantia nigra responses to novelty in healthy human participants. Neuropsychopharmacology 40: 831\u2013838.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR150","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.biopsych.2015.07.018","volume":"80","author":"NA Harrison","year":"2015","unstructured":"Harrison NA, Voon V, Cercignani M, Cooper EA, Pessiglione M, Critchley HD (2015b). A neurocomputational account of how inflammation enhances sensitivity to punishments versus rewards. Biol Psychiatry 80: 73\u201381.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR151","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/schbul\/sbu102","volume":"41","author":"MN Hartmann","year":"2015","unstructured":"Hartmann MN, Hager OM, Reimann AV, Chumbley JR, Kirschner M, Seifritz E et al (2015). Apathy but not diminished expression in schizophrenia is associated with discounting of monetary rewards by physical effort. Schizophr Bull 41: 503\u2013512.","journal-title":"Schizophr Bull"},{"key":"BFnpp2016143_CR152","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1074\/jbc.C115.680488","volume":"291","author":"H Haruki","year":"2016","unstructured":"Haruki H, Hovius R, Pedersen MG, Johnsson K (2016). Tetrahydrobiopterin biosynthesis as a potential target of the kynurenine pathway metabolite xanthurenic acid. J Biol Chem 291: 652\u2013657.","journal-title":"J Biol Chem"},{"key":"BFnpp2016143_CR153","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1196\/annals.1296.047","volume":"1018","author":"R Hashimoto","year":"2004","unstructured":"Hashimoto R, Nagatsu T, Ohta T, Mizutani M, Omura I (2004). Changes in the concentrations of tetrahydrobiopterin, the cofactor of tyrosine hydroxylase, in blood under physical stress and in depression. Ann NY Acad Sci 1018: 378\u2013386.","journal-title":"Ann NY Acad Sci"},{"key":"BFnpp2016143_CR154","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/archpsyc.65.5.521","volume":"65","author":"G Hasler","year":"2008","unstructured":"Hasler G, Fromm S, Carlson PJ, Luckenbaugh DA, Waldeck T, Geraci M et al (2008). Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry 65: 521\u2013531.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2016143_CR155","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0920-9964(98)00003-6","volume":"31","author":"A Heinz","year":"1998","unstructured":"Heinz A, Knable MB, Coppola R, Gorey JG, Jones DW, Lee KS et al (1998). Psychomotor slowing, negative symptoms and dopamine receptor availability\u2014an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients. Schizophr Res 31: 19\u201326.","journal-title":"Schizophr Res"},{"key":"BFnpp2016143_CR156","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jad.2016.02.003","volume":"196","author":"R Hershenberg","year":"2016","unstructured":"Hershenberg R, Satterthwaite TD, Daldal A, Katchmar N, Moore TM, Kable JW et al (2016). Diminished effort on a progressive ratio task in both unipolar and bipolar depression. J Affect Disord 196: 97\u2013100.","journal-title":"J Affect Disord"},{"key":"BFnpp2016143_CR157","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00213-008-1088-9","volume":"197","author":"J Hirvonen","year":"2008","unstructured":"Hirvonen J, Karlsson H, Kajander J, Markkula J, Rasi-Hakala H, Nagren K et al (2008). Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET. Psychopharmacology (Berl) 197: 581\u2013590.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2016143_CR158","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0091-3057(92)90446-M","volume":"42","author":"BT Ho","year":"1992","unstructured":"Ho BT, Huo YY, Lu JG, Tansey LW, Levin VA (1992). Opioid-dopaminergic mechanisms in the potentiation of d-amphetamine discrimination by interferon-alpha. Pharmacol Biochem Behav 42: 57\u201360.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2016143_CR159","doi-asserted-by":"publisher","first-page":"16136","DOI":"10.1073\/pnas.1415191111","volume":"111","author":"GE Hodes","year":"2014","unstructured":"Hodes GE, Pfau ML, Leboeuf M, Golden SA, Christoffel DJ, Bregman D et al (2014). Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc Natl Acad Sci USA 111: 16136\u201316141.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2016143_CR160","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/schbul\/sbv090","volume":"41","author":"WP Horan","year":"2015","unstructured":"Horan WP, Reddy LF, Barch DM, Buchanan RW, Dunayevich E, Gold JM et al (2015). Effort-based decision-making paradigms for clinical trials in schizophrenia: part 2\u2014external validity and correlates. Schizophr Bull 41: 1055\u20131065.","journal-title":"Schizophr Bull"},{"key":"BFnpp2016143_CR161","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nature12475","volume":"500","author":"MW Howe","year":"2013","unstructured":"Howe MW, Tierney PL, Sandberg SG, Phillips PE, Graybiel AM (2013). Prolonged dopamine signalling in striatum signals proximity and value of distant rewards. Nature 500: 575\u2013579.","journal-title":"Nature"},{"key":"BFnpp2016143_CR162","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71: 171\u2013186.","journal-title":"Psychosom Med"},{"key":"BFnpp2016143_CR163","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.psyneuen.2015.06.001","volume":"60","author":"K Hufner","year":"2015","unstructured":"Hufner K, Oberguggenberger A, Kohl C, Geisler S, Gamper E, Meraner V et al (2015). Levels in neurotransmitter precursor amino acids correlate with mental health in patients with breast cancer. Psychoneuroendocrinology 60: 28\u201338.","journal-title":"Psychoneuroendocrinology"},{"key":"BFnpp2016143_CR164","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neulet.2006.09.093","volume":"411","author":"M Imaizumi","year":"2007","unstructured":"Imaizumi M, Kim HJ, Zoghbi SS, Briard E, Hong J, Musachio JL et al (2007). PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat. Neurosci Lett 411: 200\u2013205.","journal-title":"Neurosci Lett"},{"key":"BFnpp2016143_CR165","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbi.2014.10.006","volume":"44","author":"TK Inagaki","year":"2015","unstructured":"Inagaki TK, Muscatell KA, Irwin MR, Moieni M, Dutcher JM, Jevtic I et al (2015). The role of the ventral striatum in inflammatory-induced approach toward support figures. Brain Behav Immun 44: 247\u2013252.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2016143_CR166","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.expneurol.2008.04.037","volume":"212","author":"MM Iravani","year":"2008","unstructured":"Iravani MM, Sadeghian M, Leung CC, Tel BC, Rose S, Schapira AH et al (2008). Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response. Exp Neurol 212: 522\u2013531.","journal-title":"Exp Neurol"},{"key":"BFnpp2016143_CR167","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1758-5996-6-79","volume":"6","author":"O Jamal","year":"2014","unstructured":"Jamal O, Aneni EC, Shaharyar S, Ali SS, Parris D, McEvoy JW et al (2014). Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome. Diabetol Metabo Syndr 6: 79\u201386.","journal-title":"Diabetol Metabo Syndr"},{"key":"BFnpp2016143_CR168","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1073\/pnas.0913572107","volume":"107","author":"SW Jang","year":"2010","unstructured":"Jang SW, Liu X, Yepes M, Shepherd KR, Miller GW, Liu Y et al (2010). A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc Natl Acad Sci USA 107: 2687\u20132692.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2016143_CR169","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/01.jcp.0000144893.29987.e5","volume":"24","author":"N Jayaram-Lindstrom","year":"2004","unstructured":"Jayaram-Lindstrom N, Wennberg P, Hurd YL, Franck J (2004). Effects of naltrexone on the subjective response to amphetamine in healthy volunteers. J Clin Psychopharmacol 24: 665\u2013669.","journal-title":"J Clin Psychopharmacol"},{"key":"BFnpp2016143_CR170","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s002130000549","volume":"152","author":"FD Juengling","year":"2000","unstructured":"Juengling FD, Ebert D, Gut O, Engelbrecht MA, Rasenack J, Nitzsche EU et al (2000). Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology (Berl) 152: 383\u2013389.","journal-title":"Psychopharmacology (Berl)"},{"issue":"Pt 6","key":"BFnpp2016143_CR171","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1093\/brain\/124.6.1125","volume":"124","author":"V Kaasinen","year":"2001","unstructured":"Kaasinen V, Nurmi E, Bruck A, Eskola O, Bergman J, Solin O et al (2001). Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex. Brain 124 (Pt 6): 1125\u20131130.","journal-title":"Brain"},{"key":"BFnpp2016143_CR172","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jamapsychiatry.2015.0071","volume":"72","author":"RH Kaiser","year":"2015","unstructured":"Kaiser RH, Andrews-Hanna JR, Wager TD, Pizzagalli DA (2015). Large-scale network dysfunction in major depressive disorder: a meta-analysis of resting-state functional connectivity. JAMA Psychiatry 72: 603\u2013611.","journal-title":"JAMA Psychiatry"},{"key":"BFnpp2016143_CR173","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0924-977X(99)00067-X","volume":"10","author":"M Kamata","year":"2000","unstructured":"Kamata M, Higuchi H, Yoshimoto M, Yoshida K, Shimizu T (2000). Effect of single intracerebroventricular injection of alpha-interferon on monoamine concentrations in the rat brain. Eur Neuropsychopharmacol 10: 129\u2013132.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1 Pt 1","key":"BFnpp2016143_CR174","first-page":"E163","volume":"258","author":"G Katsuura","year":"1990","unstructured":"Katsuura G, Arimura A, Koves K, Gottschall PE (1990). Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1 beta-induced ACTH release. Am J Physiol 258 (1 Pt 1): E163\u2013E171.","journal-title":"Am J Physiol"},{"key":"BFnpp2016143_CR175","doi-asserted-by":"publisher","first-page":"G508","DOI":"10.1152\/ajpgi.00269.2003","volume":"286","author":"H Kazumori","year":"2004","unstructured":"Kazumori H, Ishihara S, Rumi MA, Ortega-Cava CF, Kadowaki Y, Kinoshita Y (2004). Transforming growth factor-alpha directly augments histidine decarboxylase and vesicular monoamine transporter 2 production in rat enterochromaffin-like cells. Am J Physiol Gastrointest Liver Physiol 286: G508\u2013G514.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFnpp2016143_CR176","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.biopsych.2005.04.035","volume":"58","author":"PA Keedwell","year":"2005","unstructured":"Keedwell PA, Andrew C, Williams SC, Brammer MJ, Phillips ML (2005). A double dissociation of ventromedial prefrontal cortical responses to sad and happy stimuli in depressed and healthy individuals. Biol Psychiatry 58: 495\u2013503.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR177","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/schbul\/sbu157","volume":"41","author":"M Kenk","year":"2015","unstructured":"Kenk M, Selvanathan T, Rao N, Suridjan I, Rusjan P, Remington G et al (2015). Imaging neuroinflammation in gray and white matter in schizophrenia: an in vivo PET study with [18F]-FEPPA. Schizophr Bull 41: 85\u201393.","journal-title":"Schizophr Bull"},{"key":"BFnpp2016143_CR178","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/0148607104028006410","volume":"28","author":"L Khaodhiar","year":"2004","unstructured":"Khaodhiar L, Ling PR, Blackburn GL, Bistrian BR (2004). Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. JPEN J Parenter Enteral Nutr 28: 410\u2013415.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"BFnpp2016143_CR179","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0006-8993(03)02776-8","volume":"978","author":"T Kitagami","year":"2003","unstructured":"Kitagami T, Yamada K, Miura H, Hashimoto R, Nabeshima T, Ohta T (2003). Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood-brain barrier. Brain Res 978: 104\u2013114.","journal-title":"Brain Res"},{"key":"BFnpp2016143_CR180","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0925-4927(99)00009-8","volume":"90","author":"A Klimke","year":"1999","unstructured":"Klimke A, Larisch R, Janz A, Vosberg H, Muller-Gartner HW, Gaebel W (1999). Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT. Psychiatry Res 90: 91\u2013101.","journal-title":"Psychiatry Res"},{"key":"BFnpp2016143_CR181","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00213-006-0686-7","volume":"191","author":"B Knutson","year":"2007","unstructured":"Knutson B, Gibbs SE (2007). Linking nucleus accumbens dopamine and blood oxygenation. Psychopharmacology 191: 813\u2013822.","journal-title":"Psychopharmacology"},{"key":"BFnpp2016143_CR182","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","volume":"71","author":"O K\u00f6hler","year":"2014","unstructured":"K\u00f6hler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O et al (2014). Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 71: 1381\u20131391.","journal-title":"JAMA Psychiatry"},{"key":"BFnpp2016143_CR183","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.psychres.2009.10.012","volume":"185","author":"M Kosel","year":"2011","unstructured":"Kosel M, Bilkei-Gorzo A, Zawatzky R, Zimmer A, Schlaepfer TE (2011). Pegylated human interferon alpha 2a does not induce depression-associated changes in mice. Psychiatry Res 185: 243\u2013247.","journal-title":"Psychiatry Res"},{"key":"BFnpp2016143_CR184","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1176\/appi.ajp.2012.12010109","volume":"170","author":"AM Kring","year":"2013","unstructured":"Kring AM, Gur RE, Blanchard JJ, Horan WP, Reise SP (2013). The clinical assessment interview for negative symptoms (CAINS): final development and validation. Am J Psychiatry 170: 165\u2013172.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR185","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0024-3205(00)00660-3","volume":"67","author":"T Kumai","year":"2000","unstructured":"Kumai T, Tateishi T, Tanaka M, Watanabe M, Shimizu H, Kobayashi S (2000). Effect of interferon-alpha on tyrosine hydroxylase and catecholamine levels in the brain of rats. Life Sci 67: 663\u2013669.","journal-title":"Life Sci"},{"key":"BFnpp2016143_CR186","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/1073858409338217","volume":"15","author":"Y Kumakura","year":"2009","unstructured":"Kumakura Y, Cumming P (2009). PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches. Neuroscientist 15: 635\u2013650.","journal-title":"Neuroscientist"},{"key":"BFnpp2016143_CR187","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/sj.jcbfm.9600202","volume":"26","author":"Y Kumakura","year":"2006","unstructured":"Kumakura Y, Gjedde A, Danielsen EH, Christensen S, Cumming P (2006). Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms. J Cereb Blood Flow Metab 26: 358\u2013370.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2016143_CR188","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s13365-010-0003-4","volume":"17","author":"AM Kumar","year":"2011","unstructured":"Kumar AM, Ownby RL, Waldrop-Valverde D, Fernandez B, Kumar M (2011). Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. J Neurovirol 17: 26\u201340.","journal-title":"J Neurovirol"},{"key":"BFnpp2016143_CR189","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.neuron.2011.03.025","volume":"70","author":"S Lammel","year":"2011","unstructured":"Lammel S, Ion DI, Roeper J, Malenka RC (2011). Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron 70: 855\u2013862.","journal-title":"Neuron"},{"key":"BFnpp2016143_CR190","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nature11527","volume":"491","author":"S Lammel","year":"2012","unstructured":"Lammel S, Lim BK, Ran C, Huang KW, Betley MJ, Tye KM et al (2012). Input-specific control of reward and aversion in the ventral tegmental area. Nature 491: 212\u2013217.","journal-title":"Nature"},{"key":"BFnpp2016143_CR191","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","volume":"22","author":"S Lanquillon","year":"2000","unstructured":"Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22: 370\u2013379.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR192","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1471-4159.1993.tb03191.x","volume":"60","author":"J Lavicky","year":"1993","unstructured":"Lavicky J, Dunn AJ (1993). Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem 60: 602\u2013612.","journal-title":"J Neurochem"},{"key":"BFnpp2016143_CR193","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/syn.10285","volume":"51","author":"M Le Masurier","year":"2004","unstructured":"Le Masurier M, Houston G, Cowen P, Grasby P, Sharp T, Hume S (2004). Tyrosine-free amino acid mixture attenuates amphetamine-induced displacement of [11C]raclopride in striatum in vivo: a rat PET study. Synapse 51: 151\u2013157.","journal-title":"Synapse"},{"key":"BFnpp2016143_CR194","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbr.2014.06.045","volume":"272","author":"A Lebena","year":"2014","unstructured":"Lebena A, Vegas O, Gomez-Lazaro E, Arregi A, Garmendia L, Beitia G et al (2014). Melanoma tumors alter proinflammatory cytokine production and monoamine brain function, and induce depressive-like behavior in male mice. Behav Brain Res 272: 83\u201392.","journal-title":"Behav Brain Res"},{"key":"BFnpp2016143_CR195","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1136\/jnnp.49.8.853","volume":"49","author":"KL Leenders","year":"1986","unstructured":"Leenders KL, Palmer AJ, Quinn N, Clark JC, Firnau G, Garnett ES et al (1986). Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. J Neurol Neurosurg Psychiatry 49: 853\u2013860.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFnpp2016143_CR196","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/mds.10387","volume":"18","author":"AF Leentjens","year":"2003","unstructured":"Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR (2003). Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 18: 414\u2013418.","journal-title":"Mov Disord"},{"key":"BFnpp2016143_CR197","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-0447.1999.tb07221.x","volume":"99","author":"MR Lemke","year":"1999","unstructured":"Lemke MR, Puhl P, Koethe N, Winkler T (1999). Psychomotor retardation and anhedonia in depression. Acta Psychiatr Scand 99: 252\u2013256.","journal-title":"Acta Psychiatr Scand"},{"key":"BFnpp2016143_CR198","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000026615","volume":"40","author":"J Levine","year":"1999","unstructured":"Levine J, Barak Y, Chengappa KN, Rapoport A, Rebey M, Barak V (1999). Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40: 171\u2013176.","journal-title":"Neuropsychobiology"},{"key":"BFnpp2016143_CR199","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.npp.1300328","volume":"29","author":"M Leyton","year":"2004","unstructured":"Leyton M, Dagher A, Boileau I, Casey K, Baker GB, Diksic M et al (2004). Decreasing amphetamine-induced dopamine release by acute phenylalanine\/tyrosine depletion: A PET\/[11C]raclopride study in healthy men. Neuropsychopharmacology 29: 427\u2013432.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR200","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1046\/j.1471-4159.2003.01890.x","volume":"86","author":"W Li","year":"2003","unstructured":"Li W, Knowlton D, Woodward WR, Habecker BA (2003). Regulation of noradrenergic function by inflammatory cytokines and depolarization. J Neurochem 86: 774\u2013783.","journal-title":"J Neurochem"},{"key":"BFnpp2016143_CR201","doi-asserted-by":"publisher","first-page":"e28370","DOI":"10.1371\/journal.pone.0028370","volume":"7","author":"J Liggins","year":"2012","unstructured":"Liggins J, Pihl RO, Benkelfat C, Leyton M (2012). The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers. PLoS ONE 7: e28370.","journal-title":"PLoS ONE"},{"key":"BFnpp2016143_CR202","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1001\/archinte.165.8.910","volume":"165","author":"W Lim","year":"2005","unstructured":"Lim W, Hong S, Nelesen R, Dimsdale JE (2005). The association of obesity, cytokine levels, and depressive symptoms with diverse measures of fatigue in healthy subjects. Arch Intern Med 165: 910\u2013915.","journal-title":"Arch Intern Med"},{"key":"BFnpp2016143_CR203","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.biopsych.2009.01.030","volume":"66","author":"D Lindqvist","year":"2009","unstructured":"Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, Minthon L et al (2009). Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 66: 287\u2013292.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR204","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0969-8051(02)00410-9","volume":"30","author":"A Lockhart","year":"2003","unstructured":"Lockhart A, Davis B, Matthews JC, Rahmoune H, Hong G, Gee A et al (2003). The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant \u03b11-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker. Nucl Med Biol 30: 199\u2013206.","journal-title":"Nucl Med Biol"},{"key":"BFnpp2016143_CR205","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.pnpbp.2006.04.004","volume":"30","author":"JM Loftis","year":"2006","unstructured":"Loftis JM, Hauser P, Macey TA, Lowe JD (2006a). Can rodents be used to model interferon-alpha-induced depressive symptoms? Prog Neuropsychopharmacol Biol Psychiatry 30: 1364\u20131365.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp2016143_CR206","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.psyneuen.2006.07.006","volume":"31","author":"JM Loftis","year":"2006","unstructured":"Loftis JM, Wall JM, Pagel RL, Hauser P (2006b). Administration of pegylated interferon-alpha-2a or -2b does not induce sickness behavior in Lewis rats. Psychoneuroendocrinology 31: 1289\u20131294.","journal-title":"Psychoneuroendocrinology"},{"key":"BFnpp2016143_CR207","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.1523\/JNEUROSCI.1746-05.2005","volume":"25","author":"J Lotharius","year":"2005","unstructured":"Lotharius J, Falsig J, van Beek J, Payne S, Dringen R, Brundin P et al (2005). Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci 25: 6329\u20136342.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR208","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-0-585-37970-8_2","volume":"461","author":"M Maes","year":"1999","unstructured":"Maes M (1999). Major depression and activation of the inflammatory response system. Adv Exp Med Biol 461: 25\u201346.","journal-title":"Adv Exp Med Biol"},{"key":"BFnpp2016143_CR209","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/S0033291700032712","volume":"22","author":"M Maes","year":"1992","unstructured":"Maes M, Lambrechts J, Bosmans E, Jacobs J, Suy E, Vandervorst C et al (1992). Evidencess for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 22: 45\u201353.","journal-title":"Psychol Med"},{"key":"BFnpp2016143_CR210","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.bbi.2007.12.009","volume":"22","author":"M Majer","year":"2008","unstructured":"Majer M, Welberg LA, Capuron L, Pagnoni G, Raison CL, Miller AH (2008). IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain Behav Immun 22: 870\u2013880.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2016143_CR211","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0006-8993(99)02235-0","volume":"852","author":"M Makino","year":"2000","unstructured":"Makino M, Kitano Y, Komiyama C, Hirohashi M, Kohno M, Moriyama M et al (2000a). Human interferon-alpha induces immobility in the mouse forced swimming test: involvement of the opioid system. Brain Res 852: 482\u2013484.","journal-title":"Brain Res"},{"key":"BFnpp2016143_CR212","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s002130050031","volume":"148","author":"M Makino","year":"2000","unstructured":"Makino M, Kitano Y, Komiyama C, Takasuna K (2000b). Human interferon-alpha increases immobility in the forced swimming test in rats. Psychopharmacology (Berl) 148: 106\u2013110.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2016143_CR213","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00520-007-0341-9","volume":"16","author":"HG Mar Fan","year":"2008","unstructured":"Mar Fan HG, Clemons M, Xu W, Chemerynsky I, Breunis H, Braganza S et al (2008). A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer 16: 577\u2013583.","journal-title":"Support Care Cancer"},{"key":"BFnpp2016143_CR214","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.nbd.2012.12.016","volume":"54","author":"SA Marshall","year":"2013","unstructured":"Marshall SA, McClain JA, Kelso ML, Hopkins DM, Pauly JR, Nixon K (2013). Microglial activation is not equivalent to neuroinflammation in alcohol-induced neurodegeneration: The importance of microglia phenotype. Neurobiol Dis 54: 239\u2013251.","journal-title":"Neurobiol Dis"},{"key":"BFnpp2016143_CR215","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/da.20876","volume":"29","author":"JM Martinez","year":"2012","unstructured":"Martinez JM, Garakani A, Yehuda R, Gorman JM (2012). Proinflammatory and \"resiliency\" proteins in the CSF of patients with major depression. Depress Anxiety 29: 32\u201338.","journal-title":"Depress Anxiety"},{"key":"BFnpp2016143_CR216","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1176\/appi.ajp.158.2.314","volume":"158","author":"M Martinot","year":"2001","unstructured":"Martinot M, Bragulat V, Artiges E, Dolle F, Hinnen F, Jouvent R et al (2001). Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. Am J Psychiatry 158: 314\u2013316.","journal-title":"Am J Psychiatry"},{"issue":"Pt 7","key":"BFnpp2016143_CR217","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1093\/brain\/awr137","volume":"134","author":"GJ Masilamoni","year":"2011","unstructured":"Masilamoni GJ, Bogenpohl JW, Alagille D, Delevich K, Tamagnan G, Votaw JR et al (2011). Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys. Brain 134 (Pt 7): 2057\u20132073.","journal-title":"Brain"},{"key":"BFnpp2016143_CR218","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0143-4179(89)90085-1","volume":"13","author":"I Matsuzaki","year":"1989","unstructured":"Matsuzaki I, Takamatsu Y, Moroji T (1989). The effects of intracerebroventricularly injected corticotropin-releasing factor (CRF) on the central nervous system: behavioural and biochemical studies. Neuropeptides 13: 147\u2013155.","journal-title":"Neuropeptides"},{"key":"BFnpp2016143_CR219","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.schres.2015.12.017","volume":"170","author":"JM McCarthy","year":"2016","unstructured":"McCarthy JM, Treadway MT, Bennett ME, Blanchard JJ (2016). Inefficient effort allocation and negative symptoms in individuals with schizophrenia. Schizophr Res 170: 278\u2013284.","journal-title":"Schizophr Res"},{"key":"BFnpp2016143_CR220","first-page":"735","volume":"32","author":"WT McKinney Jr.","year":"1971","unstructured":"McKinney WT Jr., Eising RG, Moran EC, Suomi SJ, Harlow HF (1971). Effects of reserpine on the social behavior of rhesus monkeys. Dis Nerv Syst 32: 735\u2013741.","journal-title":"Dis Nerv Syst"},{"key":"BFnpp2016143_CR221","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00213-003-1586-8","volume":"171","author":"A McLean","year":"2004","unstructured":"McLean A, Rubinsztein JS, Robbins TW, Sahakian BJ (2004). The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression. Psychopharmacology 171: 286\u2013297.","journal-title":"Psychopharmacology"},{"key":"BFnpp2016143_CR222","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jacc.2003.07.050","volume":"43","author":"HK Meier-Ewert","year":"2004","unstructured":"Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF et al (2004). Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43: 678\u2013683.","journal-title":"J Am Coll Cardiol"},{"key":"BFnpp2016143_CR223","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1038\/sj.npp.1301615","volume":"33","author":"F Meisner","year":"2008","unstructured":"Meisner F, Scheller C, Kneitz S, Sopper S, Neuen-Jacob E, Riederer P et al (2008). Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology 33: 2228\u20132236.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR224","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/jlb.59.3.341","volume":"59","author":"M Mekaouche","year":"1996","unstructured":"Mekaouche M, Siaud P, Givalois L, Barbanel G, Malaval F, Maurel D et al (1996). Different responses of plasma ACTH and corticosterone and of plasma interleukin-1 beta to single and recurrent endotoxin challenges. J Leukoc Biol 59: 341\u2013346.","journal-title":"J Leukoc Biol"},{"key":"BFnpp2016143_CR225","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1176\/appi.ajp.159.5.746","volume":"159","author":"MJ Mentis","year":"2002","unstructured":"Mentis MJ, McIntosh AR, Perrine K, Dhawan V, Berlin B, Feigin A et al (2002). Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am J Psychiatry 159: 746\u2013754.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR226","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.neuroimage.2011.08.028","volume":"59","author":"M Michaelides","year":"2012","unstructured":"Michaelides M, Thanos PK, Kim R, Cho J, Ananth M, Wang GJ et al (2012). PET imaging predicts future body weight and cocaine preference. Neuroimage 59: 1508\u20131513.","journal-title":"Neuroimage"},{"key":"BFnpp2016143_CR227","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1176\/appi.ajp.2014.14020263","volume":"172","author":"V Michopoulos","year":"2015","unstructured":"Michopoulos V, Rothbaum AO, Jovanovic T, Almli LM, Bradley B, Rothbaum BO et al (2015). Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am J Psychiatry 172: 353\u2013362.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR228","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1200\/JCO.2007.10.7805","volume":"26","author":"AH Miller","year":"2008","unstructured":"Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR (2008). Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26: 971\u2013982.","journal-title":"J Clin Oncol"},{"key":"BFnpp2016143_CR229","doi-asserted-by":"publisher","first-page":"e98156","DOI":"10.1371\/journal.pone.0098156","volume":"9","author":"AH Miller","year":"2014","unstructured":"Miller AH, Jones JF, Drake DF, Tian H, Unger ER, Pagnoni G (2014). Decreased basal ganglia activation in subjects with chronic fatigue syndrome: association with symptoms of fatigue. PLoS One 9: e98156.","journal-title":"PLoS One"},{"key":"BFnpp2016143_CR230","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/jamapsychiatry.2015.22","volume":"72","author":"AH Miller","year":"2015","unstructured":"Miller AH, Raison CL (2015). Are anti-inflammatory therapies viable treatments for psychiatric disorders? where the rubber meets the road. JAMA Psychiatry 72: 527\u2013528.","journal-title":"JAMA Psychiatry"},{"key":"BFnpp2016143_CR231","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011). Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70: 663\u2013671.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR232","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biopsych.2012.02.034","volume":"72","author":"GE Miller","year":"2012","unstructured":"Miller GE, Cole SW (2012). Clustering of depression and inflammation in adolescents previously exposed to childhood adversity. Biol Psychiatry 72: 34\u201340.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR233","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0889-1591(03)00057-6","volume":"17","author":"GE Miller","year":"2003","unstructured":"Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA (2003). Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun 17: 276\u2013285.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2016143_CR234","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0002-9149(02)02863-1","volume":"90","author":"GE Miller","year":"2002","unstructured":"Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA (2002). Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 90: 1279\u20131283.","journal-title":"Am J Cardiol"},{"key":"BFnpp2016143_CR235","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4088\/JCP.v62n0314a","volume":"62","author":"PB Mitchell","year":"2001","unstructured":"Mitchell PB, Wilhelm K, Parker G, Austin MP, Rutgers P, Malhi GS (2001). The clinical features of bipolar depression: a comparison with matched major depressive disorder patients. J Clin Psychiatry 62: 212\u2013216.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2016143_CR236","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/00001756-200302100-00003","volume":"14","author":"MT Mitterschiffthaler","year":"2003","unstructured":"Mitterschiffthaler MT, Kumari V, Malhi GS, Brown RG, Giampietro VP, Brammer MJ et al (2003). Neural response to pleasant stimuli in anhedonia: an fMRI study. Neuroreport 14: 177\u2013182.","journal-title":"Neuroreport"},{"key":"BFnpp2016143_CR237","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1200\/JCO.2010.28.1444","volume":"28","author":"AR Moraska","year":"2010","unstructured":"Moraska AR, Sood A, Dakhil SR, Sloan JA, Barton D, Atherton PJ et al (2010). Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol 28: 3673\u20133679.","journal-title":"J Clin Oncol"},{"key":"BFnpp2016143_CR238","doi-asserted-by":"publisher","first-page":"8480","DOI":"10.1523\/JNEUROSCI.23-24-08480.2003","volume":"23","author":"JA Moron","year":"2003","unstructured":"Moron JA, Zakharova I, Ferrer JV, Merrill GA, Hope B, Lafer EM et al (2003). Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci 23: 8480\u20138488.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR239","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/schbul\/sbl051","volume":"33","author":"M Morrens","year":"2007","unstructured":"Morrens M, Hulstijn W, Sabbe B (2007). Psychomotor slowing in schizophrenia. Schizophr Bull 33: 1038\u20131053.","journal-title":"Schizophr Bull"},{"key":"BFnpp2016143_CR240","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/mp.2011.75","volume":"17","author":"RW Morris","year":"2011","unstructured":"Morris RW, Vercammen A, Lenroot R, Moore L, Langton JM, Short B et al (2011). Disambiguating ventral striatum fMRI-related bold signal during reward prediction in schizophrenia. Mol Psychiatry 17: 280\u2013289.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016143_CR241","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1200\/JCO.2003.04.070","volume":"21","author":"GR Morrow","year":"2003","unstructured":"Morrow GR, Hickok JT, Roscoe JA, Raubertas RF, Andrews PL, Flynn PJ et al (2003). Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 21: 4635\u20134641.","journal-title":"J Clin Oncol"},{"key":"BFnpp2016143_CR242","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/mp.2013.161","volume":"19","author":"S Mostafavi","year":"2014","unstructured":"Mostafavi S, Battle A, Zhu X, Potash JB, Weissman MM, Shi J et al (2014). Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing. Mol Psychiatry 19: 1267\u20131274.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016143_CR243","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/01.psy.0000149259.72488.09","volume":"67","author":"SJ Motivala","year":"2005","unstructured":"Motivala SJ, Sarfatti A, Olmos L, Irwin MR (2005). Inflammatory markers and sleep disturbance in major depression. Psychosom Med 67: 187\u2013194.","journal-title":"Psychosom Med"},{"key":"BFnpp2016143_CR244","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbi.2016.03.022","volume":"57","author":"Keely A. Muscatell","year":"2016","unstructured":"Muscatell KA, Moieni M, Inagaki TK, Dutcher JM, Jevtic I, Breen EC et al (2016). Exposure to an inflammatory challenge enhances neural sensitivity to negative and positive social feedback. Brain Behav Immun (in press).","journal-title":"Brain, Behavior, and Immunity"},{"key":"BFnpp2016143_CR245","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1056\/NEJM200103293441303","volume":"344","author":"DL Musselman","year":"2001","unstructured":"Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS et al (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344: 961\u2013966.","journal-title":"N Engl J Med"},{"key":"BFnpp2016143_CR246","first-page":"142","volume":"10","author":"S Najjar","year":"2013","unstructured":"Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D (2013). Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation 10: 142.","journal-title":"J Neuroinflammation"},{"key":"BFnpp2016143_CR247","doi-asserted-by":"publisher","first-page":"622","DOI":"10.2174\/138920008785821738","volume":"9","author":"G Neurauter","year":"2008","unstructured":"Neurauter G, Schrocksnadel K, Scholl-Burgi S, Sperner-Unterweger B, Schubert C, Ledochowski M et al (2008). Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr Drug Metab 9: 622\u2013627.","journal-title":"Curr Drug Metab"},{"key":"BFnpp2016143_CR248","doi-asserted-by":"publisher","first-page":"e1480","DOI":"10.4088\/JCP.13097TX1C","volume":"76","author":"AA Nierenberg","year":"2015","unstructured":"Nierenberg AA (2015). Residual symptoms in depression: prevalence and impact. J Clin Psychiatry 76: e1480.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2016143_CR249","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00213-006-0502-4","volume":"191","author":"Y Niv","year":"2007","unstructured":"Niv Y, Daw ND, Joel D, Dayan P (2007). Tonic dopamine: opportunity costs and the control of response vigor. Psychopharmacology 191: 507\u2013520.","journal-title":"Psychopharmacology"},{"key":"BFnpp2016143_CR250","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00213-013-3285-4","volume":"231","author":"EJ Nunes","year":"2014","unstructured":"Nunes EJ, Randall PA, Estrada A, Epling B, Hart EE, Lee CA et al (2014). Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5\/ chow feeding choice task. Psychopharmacology (Berl) 231: 727\u2013736.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2016143_CR251","doi-asserted-by":"publisher","first-page":"19120","DOI":"10.1523\/JNEUROSCI.2730-13.2013","volume":"33","author":"EJ Nunes","year":"2013","unstructured":"Nunes EJ, Randall PA, Hart EE, Freeland C, Yohn SE, Baqi Y et al (2013). Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. J Neurosci 33: 19120\u201319130.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR252","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.biopsych.2015.05.017","volume":"80","author":"R Nusslock","year":"2015","unstructured":"Nusslock R, Miller GE (2015). Early-life adversity and physical and emotional health across the lifespan: a neuroimmune network hypothesis. Biol Psychiatry 80: 23\u201332.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR253","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/0269881106069938","volume":"21","author":"D Nutt","year":"2007","unstructured":"Nutt D, Demyttenaere K, Janka Z, Aarre T, Bourin M, Canonico PL et al (2007). The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J Psychopharmacol 21: 461\u2013471.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2016143_CR254","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.4049\/jimmunol.0802722","volume":"182","author":"JC O'Connor","year":"2009","unstructured":"O'Connor JC, Lawson MA, Andre C, Briley EM, Szegedi SS, Lestage J et al (2009a). Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J Immunol 182: 3202\u20133212.","journal-title":"J Immunol"},{"key":"BFnpp2016143_CR255","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"JC O'Connor","year":"2008","unstructured":"O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N et al (2008). Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14: 511\u2013522.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016143_CR256","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"JC O'Connor","year":"2009","unstructured":"O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N et al (2009b). Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14: 511\u2013522.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016143_CR257","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1126\/science.1094285","volume":"304","author":"J O'Doherty","year":"2004","unstructured":"O'Doherty J, Dayan P, Schultz J, Deichmann R, Friston K, Dolan RJ (2004). Dissociable roles of ventral and dorsal striatum in instrumental conditioning. Science 304: 452\u2013454.","journal-title":"Science"},{"key":"BFnpp2016143_CR258","first-page":"570","volume-title":"Psychoneuroimmunology","author":"MR Opp","year":"2007","unstructured":"Opp MR, Born J, Irwin MR (2007). Sleep and the immune systemIn: Ader R (ed). Psychoneuroimmunology. Academic Press: New York, NY, USA. pp 570\u2013618."},{"key":"BFnpp2016143_CR259","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000201718","volume":"58","author":"AS Orsal","year":"2008","unstructured":"Orsal AS, Blois SM, Bermpohl D, Schaefer M, Coquery N (2008). Administration of interferon-alpha in mice provokes peripheral and central modulation of immune cells, accompanied by behavioral effects. Neuropsychobiology 58: 211\u2013222.","journal-title":"Neuropsychobiology"},{"key":"BFnpp2016143_CR260","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/hup.2426","volume":"29","author":"K Oya","year":"2014","unstructured":"Oya K, Kishi T, Iwata N (2014). Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials. Hum Psychopharmacol 29: 483\u2013491.","journal-title":"Hum Psychopharmacol"},{"key":"BFnpp2016143_CR261","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1176\/ajp.2006.163.9.1630","volume":"163","author":"TW Pace","year":"2006","unstructured":"Pace TW, Mletzko TC, Alagbe O, Musselman DL, Nemeroff CB, Miller AH et al (2006). Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry 163: 1630\u20131633.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR262","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fimmu.2014.00117","volume":"5","author":"R Pacheco","year":"2014","unstructured":"Pacheco R, Contreras F, Zouali M (2014). The dopaminergic system in autoimmune diseases. Front Immunol 5: 117.","journal-title":"Front Immunol"},{"key":"BFnpp2016143_CR263","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bcr.03.2011.3927.corr1","volume":"2011","author":"L Pan","year":"2011","unstructured":"Pan L, McKain BW, Madan-Khetarpal S, McGuire M, Diler RS, Perel JM et al (2011). GTP-cyclohydrolase deficiency responsive to sapropterin and 5-HTP supplementation: relief of treatment-refractory depression and suicidal behaviour. BMJ Case Rep 2011: 1\u20133.","journal-title":"BMJ Case Rep"},{"key":"BFnpp2016143_CR264","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2174\/1381612033455332","volume":"9","author":"W Pan","year":"2003","unstructured":"Pan W, Kastin AJ (2003). Interactions of cytokines with the blood-brain barrier: implications for feeding. Curr Pharm Des 9: 827\u2013831.","journal-title":"Curr Pharm Des"},{"key":"BFnpp2016143_CR265","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1176\/appi.ajp.2009.09081198","volume":"167","author":"GI Papakostas","year":"2010","unstructured":"Papakostas GI, Mischoulon D, Shyu I, Alpert JE, Fava M (2010). S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J Psychiatry 167: 942\u2013948.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR266","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.4088\/JCP.v65n0811","volume":"65","author":"GI Papakostas","year":"2004","unstructured":"Papakostas GI, Petersen T, Mischoulon D, Green CH, Nierenberg AA, Bottiglieri T et al (2004a). Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy. J Clin Psychiatry 65: 1096\u20131098.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2016143_CR267","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.4088\/JCP.v65n0810","volume":"65","author":"GI Papakostas","year":"2004","unstructured":"Papakostas GI, Petersen T, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T et al (2004b). Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry 65: 1090\u20131095.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2016143_CR268","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1176\/appi.ajp.2012.11071114","volume":"169","author":"GI Papakostas","year":"2012","unstructured":"Papakostas GI, Shelton RC, Zajecka JM, Etemad B, Rickels K, Clain A et al (2012). L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry 169: 1267\u20131274.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR269","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.diabres.2004.11.007","volume":"69","author":"HS Park","year":"2005","unstructured":"Park HS, Park JY, Yu R (2005). Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 69: 29\u201335.","journal-title":"Diabetes Res Clin Pract"},{"key":"BFnpp2016143_CR270","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1176\/appi.ajp.2010.09101525","volume":"167","author":"G Parker","year":"2010","unstructured":"Parker G, Fink M, Shorter E, Taylor MA, Akiskal H, Berrios G et al (2010). Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder. Am J Psychiatry 167: 745\u2013747.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR271","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0006-3223(01)01089-7","volume":"50","author":"RV Parsey","year":"2001","unstructured":"Parsey RV, Oquendo MA, Zea-Ponce Y, Rodenhiser J, Kegeles LS, Pratap M et al (2001). Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression. Biol Psychiatry 50: 313\u2013322.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR272","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/nature05051","volume":"442","author":"M Pessiglione","year":"2006","unstructured":"Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD (2006). Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442: 1042\u20131045.","journal-title":"Nature"},{"key":"BFnpp2016143_CR273","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00213-006-0626-6","volume":"191","author":"PE Phillips","year":"2007","unstructured":"Phillips PE, Walton ME, Jhou TC (2007). Calculating utility: preclinical evidence for cost-benefit analysis by mesolimbic dopamine. Psychopharmacology (Berl) 191: 483\u2013495.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2016143_CR274","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-clinpsy-050212-185606","volume":"10","author":"DA Pizzagalli","year":"2014","unstructured":"Pizzagalli DA (2014). Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu Rev Clin Psychol 10: 393\u2013423.","journal-title":"Annu Rev Clin Psychol"},{"key":"BFnpp2016143_CR275","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1176\/appi.ajp.2008.08081201","volume":"166","author":"DA Pizzagalli","year":"2009","unstructured":"Pizzagalli DA, Holmes AJ, Dillon DG, Goetz EL, Birk JL, Bogdan R et al (2009). Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry 166: 702\u2013710.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR276","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jpsychires.2008.03.001","volume":"43","author":"DA Pizzagalli","year":"2008","unstructured":"Pizzagalli DA, Iosifescu D, Hallett LA, Ratner KG, Fava M (2008). Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. J Psychiatr Res 43: 76\u201387.","journal-title":"J Psychiatr Res"},{"key":"BFnpp2016143_CR277","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1017\/S1461145702003152","volume":"5","author":"Y Pollak","year":"2002","unstructured":"Pollak Y, Yirmiya R (2002). Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol 5: 389\u2013399.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp2016143_CR278","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","volume":"63","author":"S Potvin","year":"2008","unstructured":"Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E (2008). Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63: 801\u2013808.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR279","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","volume":"66","author":"RB Price","year":"2009","unstructured":"Price RB, Nock MK, Charney DS, Mathew SJ (2009). Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry 66: 522\u2013526.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR280","doi-asserted-by":"crossref","unstructured":"Pucci E, Branas P, D'Amico R, Giuliani G, Solari A, Taus C (2007). Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev: CD002818.","DOI":"10.1002\/14651858.CD002818.pub2"},{"key":"BFnpp2016143_CR281","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1037\/a0018865","volume":"124","author":"CB Puryear","year":"2010","unstructured":"Puryear CB, Kim MJ, Mizumori SJ (2010). Conjunctive encoding of movement and reward by ventral tegmental area neurons in the freely navigating rodent. Behav Neurosci 124: 234\u2013247.","journal-title":"Behav Neurosci"},{"key":"BFnpp2016143_CR282","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.20467","volume":"55","author":"L Qin","year":"2007","unstructured":"Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS et al (2007). Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55: 453\u2013462.","journal-title":"Glia"},{"key":"BFnpp2016143_CR283","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1001\/jamapsychiatry.2015.2196","volume":"72","author":"J Radua","year":"2015","unstructured":"Radua J, Schmidt A, Borgwardt S, Heinz A, Schlagenhauf F, McGuire P et al (2015). Ventral striatal activation during reward processing in psychosis: a neurofunctional meta-analysis. JAMA psychiatry 72: 1243\u20131251.","journal-title":"JAMA psychiatry"},{"key":"BFnpp2016143_CR284","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4088\/JCP.v66n0106","volume":"66","author":"CL Raison","year":"2005","unstructured":"Raison CL, Borisov AS, Broadwell SD, Capuron L, Woolwine BJ, Jacobson IM et al (2005a). Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry 66: 41\u201348.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2016143_CR285","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.biopsych.2008.08.010","volume":"65","author":"CL Raison","year":"2009","unstructured":"Raison CL, Borisov AS, Majer M, Drake DF, Pagnoni G, Woolwine BJ et al (2009). Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry 65: 296\u2013303.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR286","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/mp.2009.116","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G et al (2010a). CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 15: 393\u2013403.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016143_CR287","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2165\/00023210-200519020-00002","volume":"19","author":"CL Raison","year":"2005","unstructured":"Raison CL, Demetrashvili M, Capuron L, Miller AH (2005b). Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs 19: 105\u2013123.","journal-title":"CNS Drugs"},{"key":"BFnpp2016143_CR288","unstructured":"Raison CL, Felger JC, Miller AH (2013a). Inflammation and treatment resistance in major depression: a perfect storm. Psychiatric Times. 12 September."},{"key":"BFnpp2016143_CR289","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0006-3223(03)00413-X","volume":"54","author":"CL Raison","year":"2003","unstructured":"Raison CL, Miller AH (2003). Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 54: 283\u2013294.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR290","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11920-011-0232-0","volume":"13","author":"CL Raison","year":"2011","unstructured":"Raison CL, Miller AH (2011). Is depression an inflammatory disorder? Curr Psychiatry Rep 13: 467\u2013475.","journal-title":"Curr Psychiatry Rep"},{"key":"BFnpp2016143_CR291","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/mp.2012.2","volume":"18","author":"CL Raison","year":"2013","unstructured":"Raison CL, Miller AH (2013). The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatry 18: 15\u201337.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016143_CR292","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF et al (2013b). A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70: 31\u201341.","journal-title":"JAMA Psychiatry"},{"key":"BFnpp2016143_CR293","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.biopsych.2010.04.019","volume":"68","author":"CL Raison","year":"2010","unstructured":"Raison CL, Rye DB, Woolwine BJ, Vogt GJ, Bautista BM, Spivey JR et al (2010b). Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol. Biol Psychiatry 68: 942\u2013949.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR294","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0165-0173(99)00007-7","volume":"30","author":"G Raivich","year":"1999","unstructured":"Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW (1999). Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Rev 30: 77\u2013105.","journal-title":"Brain Res Rev"},{"key":"BFnpp2016143_CR295","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyu017","volume":"18","author":"PA Randall","year":"2015","unstructured":"Randall PA, Lee CA, Podurgiel SJ, Hart E, Yohn SE, Jones M et al (2015). Bupropion increases selection of high effort activity in rats tested on a progressive ratio\/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms. Int J Neuropsychopharmacol 18: 1\u201311.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp2016143_CR296","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/mp.2015.22","volume":"21","author":"MH Rapaport","year":"2016","unstructured":"Rapaport MH, Nierenberg AA, Schettler PJ, Kinkead B, Cardoos A, Walker R et al (2016). Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study. Mol Psychiatry 21: 71\u201379.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016143_CR297","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/schbul\/sbv089","volume":"41","author":"LF Reddy","year":"2015","unstructured":"Reddy LF, Horan WP, Barch DM, Buchanan RW, Dunayevich E, Gold JM et al (2015). Effort-based decision-making paradigms for clinical trials in schizophrenia: part 1\u2014psychometric characteristics of 5 paradigms. Schizophr Bull 41: 1045\u20131054.","journal-title":"Schizophr Bull"},{"key":"BFnpp2016143_CR298","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.brainres.2014.02.005","volume":"1557","author":"KR Reinert","year":"2014","unstructured":"Reinert KR, Umphlet CD, Quattlebaum A, Boger HA (2014). Short-term effects of an endotoxin on substantia nigra dopamine neurons. Brain Res 1557: 164\u2013170.","journal-title":"Brain Res"},{"key":"BFnpp2016143_CR299","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nn1378","volume":"8","author":"J Reuter","year":"2005","unstructured":"Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C (2005). Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 8: 147\u2013148.","journal-title":"Nat Neurosci"},{"key":"BFnpp2016143_CR300","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/35092560","volume":"413","author":"JN Reynolds","year":"2001","unstructured":"Reynolds JN, Hyland BI, Wickens JR (2001). A cellular mechanism of reward-related learning. Nature 413: 67\u201370.","journal-title":"Nature"},{"key":"BFnpp2016143_CR301","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","volume":"107","author":"PM Ridker","year":"2003","unstructured":"Ridker PM (2003). Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107: 363\u2013369.","journal-title":"Circulation"},{"key":"BFnpp2016143_CR302","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1152\/jn.1990.63.3.592","volume":"63","author":"R Romo","year":"1990","unstructured":"Romo R, Schultz W (1990). Dopamine neurons of the monkey midbrain: contingencies of responses to active touch during self-initiated arm movements. J Neurophysiol 63: 592\u2013606.","journal-title":"J Neurophysiol"},{"key":"BFnpp2016143_CR303","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/bdi.12373","volume":"18","author":"JD Rosenblat","year":"2016","unstructured":"Rosenblat JD, Kakar R, Berk M, Kessing LV, Vinberg M, Baune BT et al (2016). Anti\u2010inflammatory agents in the treatment of bipolar depression: a systematic review and meta\u2010analysis. Bipolar Disord 18: 89\u2013101.","journal-title":"Bipolar Disord"},{"key":"BFnpp2016143_CR304","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF02244865","volume":"116","author":"S Rosenzweig-Lipson","year":"1994","unstructured":"Rosenzweig-Lipson S, Hesterberg P, Bergman J (1994). Observational studies of dopamine D1 and D2 agonists in squirrel monkeys. Psychopharmacology (Berl) 116: 9\u201318.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2016143_CR305","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1200\/JCO.2014.55.8353","volume":"32","author":"KJ Ruddy","year":"2014","unstructured":"Ruddy KJ, Barton D, Loprinzi CL (2014). Laying to rest psychostimulants for cancer-related fatigue? J Clin Oncol 32: 1865\u20131867.","journal-title":"J Clin Oncol"},{"key":"BFnpp2016143_CR306","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1176\/ajp.2007.164.2.201","volume":"164","author":"AJ Rush","year":"2007","unstructured":"Rush AJ (2007). STAR*D: what have we learned? Am J Psychiatry 164: 201\u2013204.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR307","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrn3381","volume":"14","author":"SJ Russo","year":"2013","unstructured":"Russo SJ, Nestler EJ (2013). The brain reward circuitry in mood disorders. Nat Rev Neurosci 14: 609\u2013625.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp2016143_CR308","doi-asserted-by":"publisher","first-page":"13525","DOI":"10.1523\/JNEUROSCI.1747-10.2010","volume":"30","author":"RB Rutledge","year":"2010","unstructured":"Rutledge RB, Dean M, Caplin A, Glimcher PW (2010). Testing the reward prediction error hypothesis with an axiomatic model. J Neurosci 30: 13525\u201313536.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR309","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nri3086","volume":"11","author":"K Saijo","year":"2011","unstructured":"Saijo K, Glass CK (2011). Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11: 775\u2013787.","journal-title":"Nat Rev Immunol"},{"key":"BFnpp2016143_CR310","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","volume":"76","author":"JD Salamone","year":"2012","unstructured":"Salamone JD, Correa M (2012). The mysterious motivational functions of mesolimbic dopamine. Neuron 76: 470\u2013485.","journal-title":"Neuron"},{"key":"BFnpp2016143_CR311","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0149-7634(96)00017-6","volume":"21","author":"JD Salamone","year":"1997","unstructured":"Salamone JD, Cousins MS, Snyder BJ (1997). Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Rev 21: 341\u2013359.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2016143_CR312","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S0306-4522(01)00249-4","volume":"105","author":"JD Salamone","year":"2001","unstructured":"Salamone JD, Wisniecki A, Carlson BB, Correa M (2001). Nucleus accumbens dopamine depletions make animals highly sensitive to high fixed ratio requirements but do not impair primary food reinforcement. Neuroscience 105: 863\u2013870.","journal-title":"Neuroscience"},{"key":"BFnpp2016143_CR313","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrn3917","volume":"16","author":"GR Samanez-Larkin","year":"2015","unstructured":"Samanez-Larkin GR, Knutson B (2015). Decision making in the ageing brain: changes in affective and motivational circuits. Nat Rev Neurosci 16: 278\u2013289.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp2016143_CR314","doi-asserted-by":"publisher","first-page":"12468","DOI":"10.1073\/pnas.1511003112","volume":"112","author":"CM Sandiego","year":"2015","unstructured":"Sandiego CM, Gallezot J-D, Pittman B, Nabulsi N, Lim K, Lin S-F et al (2015). Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci USA 112: 12468\u201312473.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2016143_CR315","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S0891-5849(03)00317-4","volume":"35","author":"A Santamaria","year":"2003","unstructured":"Santamaria A, Flores-Escartin A, Martinez JC, Osorio L, Galvan-Arzate S, Pedraza-Chaverri J et al (2003). Copper blocks quinolinic acid neurotoxicity in rats: contribution of antioxidant systems. Free Radic Biol Med 35: 418\u2013427.","journal-title":"Free Radic Biol Med"},{"key":"BFnpp2016143_CR316","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jad.2014.03.041","volume":"164","author":"J Sarris","year":"2014","unstructured":"Sarris J, Papakostas GI, Vitolo O, Fava M, Mischoulon D (2014). S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response. J Affect Disord 164: 76\u201381.","journal-title":"J Affect Disord"},{"key":"BFnpp2016143_CR317","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1055\/s-0035-1549928","volume":"48","author":"J Sarris","year":"2015","unstructured":"Sarris J, Price LH, Carpenter LL, Tyrka AR, Ng CH, Papakostas GI et al (2015). Is S-adenosyl methionine (SAMe) for depression only effective in males? A re-analysis of data from a randomized clinical trial. Pharmacopsychiatry 48: 141\u2013144.","journal-title":"Pharmacopsychiatry"},{"key":"BFnpp2016143_CR318","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.braindev.2013.04.003","volume":"36","author":"H Sato","year":"2014","unstructured":"Sato H, Uematsu M, Endo W, Nakayama T, Kobayashi T, Hino-Fukuyo N et al (2014). Early replacement therapy in a first Japanese case with autosomal recessive guanosine triphosphate cyclohydrolase I deficiency with a novel point mutation. Brain Dev 36: 268\u2013271.","journal-title":"Brain Dev"},{"key":"BFnpp2016143_CR319","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1440-1819.2006.01538.x","volume":"60","author":"T Sato","year":"2006","unstructured":"Sato T, Suzuki E, Yokoyama M, Semba J, Watanabe S, Miyaoka H (2006). Chronic intraperitoneal injection of interferon-alpha reduces serotonin levels in various regions of rat brain, but does not change levels of serotonin transporter mRNA, nitrite or nitrate. Psychiatry Clin Neurosci 60: 499\u2013506.","journal-title":"Psychiatry Clin Neurosci"},{"key":"BFnpp2016143_CR320","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1471-4159.2005.03373.x","volume":"95","author":"C Scheller","year":"2005","unstructured":"Scheller C, Sopper S, Jenuwein M, Neuen-Jacob E, Tatschner T, Grunblatt E et al (2005). Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation. J Neurochem 95: 377\u2013387.","journal-title":"J Neurochem"},{"key":"BFnpp2016143_CR321","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics C","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics C (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature 511: 421\u2013427.","journal-title":"Nature"},{"key":"BFnpp2016143_CR322","doi-asserted-by":"publisher","first-page":"12860","DOI":"10.1523\/JNEUROSCI.2496-07.2007","volume":"27","author":"T Sch\u00f6nberg","year":"2007","unstructured":"Sch\u00f6nberg T, Daw ND, Joel D, O'Doherty JP (2007). Reinforcement learning signals in the human striatum distinguish learners from nonlearners during reward-based decision making. J Neurosci 27: 12860\u201312867.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR323","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0896-6273(02)00967-4","volume":"36","author":"W Schultz","year":"2002","unstructured":"Schultz W (2002). Getting formal with dopamine and reward. Neuron 36: 241\u2013263.","journal-title":"Neuron"},{"key":"BFnpp2016143_CR324","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1152\/physrev.00023.2014","volume":"95","author":"W Schultz","year":"2015","unstructured":"Schultz W (2015). Neuronal reward and decision signals: from theories to data. Physiol Rev 95: 853\u2013951.","journal-title":"Physiol Rev"},{"key":"BFnpp2016143_CR325","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.102.034439","volume":"303","author":"R Schwarcz","year":"2002","unstructured":"Schwarcz R, Pellicciari R (2002). Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303: 1\u201310.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2016143_CR326","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1503\/jpn.140126","volume":"40","author":"L Schwieler","year":"2015","unstructured":"Schwieler L, Larsson MK, Skogh E, Kegel ME, Orhan F, Abdelmoaty S et al (2015). Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia\u2014significance for activation of the kynurenine pathway. J Psychiatry Neurosci 40: 126\u2013133.","journal-title":"J Psychiatry Neurosci"},{"key":"BFnpp2016143_CR327","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","volume":"72","author":"E Setiawan","year":"2015","unstructured":"Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G et al (2015). Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72: 268\u2013275.","journal-title":"JAMA Psychiatry"},{"key":"BFnpp2016143_CR328","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1017\/S0033291797005382","volume":"27","author":"PJ Shah","year":"1997","unstructured":"Shah PJ, Ogilvie AD, Goodwin GM, Ebmeier KP (1997). Clinical and psychometric correlates of dopamine D2 binding in depression. Psychol Med 27: 1247\u20131256.","journal-title":"Psychol Med"},{"key":"BFnpp2016143_CR329","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature11748","volume":"494","author":"W Shao","year":"2013","unstructured":"Shao W, Zhang SZ, Tang M, Zhang XH, Zhou Z, Yin YQ et al (2013). Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alphaB-crystallin. Nature 494: 90\u201394.","journal-title":"Nature"},{"key":"BFnpp2016143_CR330","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.cub.2012.05.053","volume":"22","author":"T Sharot","year":"2012","unstructured":"Sharot T, Guitart-Masip M, Korn CW, Chowdhury R, Dolan RJ (2012). How dopamine enhances an optimism bias in humans. Curr Biol 22: 1477\u20131481.","journal-title":"Curr Biol"},{"key":"BFnpp2016143_CR331","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/j.cub.2009.10.025","volume":"19","author":"T Sharot","year":"2009","unstructured":"Sharot T, Shiner T, Brown AC, Fan J, Dolan RJ (2009). Dopamine enhances expectation of pleasure in humans. Curr Biol 19: 2077\u20132080.","journal-title":"Curr Biol"},{"key":"BFnpp2016143_CR332","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/mp.2010.52","volume":"16","author":"RC Shelton","year":"2011","unstructured":"Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, Reddy R, Aschner M, Lewis DA et al (2011). Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 16: 751\u2013762.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016143_CR333","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.pneurobio.2010.04.004","volume":"91","author":"RC Shelton","year":"2010","unstructured":"Shelton RC, Miller AH (2010). Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol 91: 275\u2013299.","journal-title":"Prog Neurobiol"},{"key":"BFnpp2016143_CR334","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.4088\/JCP.14m09587","volume":"76","author":"RC Shelton","year":"2015","unstructured":"Shelton RC, Pencina MJ, Barrentine LW, Ruiz JA, Fava M, Zajecka JM et al (2015). Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs. J Clin Psychiatry 76: 1635\u20131641.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2016143_CR335","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1176\/appi.ps.52.11.1469","volume":"52","author":"RC Shelton","year":"2001","unstructured":"Shelton RC, Tomarken AJ (2001). Can recovery from depression be achieved? Psychiatr Serv 52: 1469\u20131478.","journal-title":"Psychiatr Serv"},{"key":"BFnpp2016143_CR336","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/1389200024605145","volume":"3","author":"H Shintaku","year":"2002","unstructured":"Shintaku H (2002). Disorders of tetrahydrobiopterin metabolism and their treatment. Curr Drug Metab 3: 123\u2013131.","journal-title":"Curr Drug Metab"},{"key":"BFnpp2016143_CR337","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0006-8993(96)01371-6","volume":"747","author":"H Shuto","year":"1997","unstructured":"Shuto H, Kataoka Y, Horikawa T, Fujihara N, Oishi R (1997). Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain. Brain Res 747: 348\u2013351.","journal-title":"Brain Res"},{"key":"BFnpp2016143_CR338","first-page":"1155","volume":"6","author":"G Sissolak","year":"1992","unstructured":"Sissolak G, Hoffbrand AV, Mehta AB, Ganeshaguru K (1992). Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts. Leukemia 6: 1155\u20131160.","journal-title":"Leukemia"},{"key":"BFnpp2016143_CR339","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-0-585-37970-8_4","volume":"461","author":"A Sluzewska","year":"1999","unstructured":"Sluzewska A (1999). Indicators of immune activation in depressed patients. Adv Exp Med Biol 461: 59\u201373.","journal-title":"Adv Exp Med Biol"},{"key":"BFnpp2016143_CR340","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000119332","volume":"35","author":"A Sluzewska","year":"1997","unstructured":"Sluzewska A, Sobieska M, Rybakowski JK (1997). Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression. Neuropsychobiology 35: 123\u2013127.","journal-title":"Neuropsychobiology"},{"key":"BFnpp2016143_CR341","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1503\/jpn.100080","volume":"36","author":"J Soderlund","year":"2011","unstructured":"Soderlund J, Olsson SK, Samuelsson M, Walther-Jallow L, Johansson C, Erhardt S et al (2011). Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder. J Psychiatry Neurosci 36: 114\u2013118.","journal-title":"J Psychiatry Neurosci"},{"key":"BFnpp2016143_CR342","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/mp.2009.52","volume":"14","author":"J Soderlund","year":"2009","unstructured":"Soderlund J, Schroder J, Nordin C, Samuelsson M, Walther-Jallow L, Karlsson H et al (2009). Activation of brain interleukin-1beta in schizophrenia. Mol Psychiatry 14: 1069\u20131071.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016143_CR343","doi-asserted-by":"publisher","first-page":"414","DOI":"10.4088\/JCP.10r06823","volume":"73","author":"IE Sommer","year":"2012","unstructured":"Sommer IE, de Witte L, Begemann M, Kahn RS (2012). Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis. J Clin Psychiatry 73 4: 414\u2013419.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2016143_CR344","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0895-6111(95)00011-E","volume":"19","author":"PG Spetsieris","year":"1995","unstructured":"Spetsieris PG, Moeller JR, Dhawan V, Ishikawa T, Eidelberg D (1995). Visualizing the evolution of abnormal metabolic networks in the brain using PET. Comput Med Imaging Graph 19: 295\u2013306.","journal-title":"Comput Med Imaging Graph"},{"key":"BFnpp2016143_CR345","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1017\/S1092852900015418","volume":"12","author":"SM Stahl","year":"2007","unstructured":"Stahl SM (2007). Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent. CNS Spectr 12: 739\u2013744.","journal-title":"CNS Spectr"},{"key":"BFnpp2016143_CR346","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1212\/01.WNL.0000158272.27070.6A","volume":"64","author":"B Stankoff","year":"2005","unstructured":"Stankoff B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L et al (2005). Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology 64: 1139\u20131143.","journal-title":"Neurology"},{"key":"BFnpp2016143_CR347","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11695-009-0015-4","volume":"20","author":"KE Steele","year":"2010","unstructured":"Steele KE, Prokopowicz GP, Schweitzer MA, Magunsuon TH, Lidor AO, Kuwabawa H et al (2010). Alterations of central dopamine receptors before and after gastric bypass surgery. Obes Surg 20: 369\u2013374.","journal-title":"Obes Surg"},{"key":"BFnpp2016143_CR348","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1017\/S1092852900016837","volume":"13","author":"DJ Stein","year":"2008","unstructured":"Stein DJ (2008). Depression, anhedonia, and psychomotor symptoms: the role of dopaminergic neurocircuitry. CNS Spectr 13: 561\u2013565.","journal-title":"CNS Spectr"},{"key":"BFnpp2016143_CR349","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1742-2094-8-94","volume":"8","author":"J Steiner","year":"2011","unstructured":"Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, Sarnyai Z et al (2011). Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation 8: 94.","journal-title":"J Neuroinflammation"},{"key":"BFnpp2016143_CR350","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1176\/appi.ajp.2011.11030447","volume":"169","author":"GP Strauss","year":"2012","unstructured":"Strauss GP, Gold JM (2012). A New Perspective on Anhedonia in Schizophrenia. Am J Psychiatry 169: 364\u2013373.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR351","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.schres.2015.12.006","volume":"170","author":"GP Strauss","year":"2016","unstructured":"Strauss GP, Whearty KM, Morra LF, Sullivan SK, Ossenfort KL, Frost KH (2016). Avolition in schizophrenia is associated with reduced willingness to expend effort for reward on a Progressive Ratio task. Schizophr Res 170: 198\u2013204.","journal-title":"Schizophr Res"},{"key":"BFnpp2016143_CR352","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1176\/appi.ajp.2015.14101298","volume":"172","author":"A Stringaris","year":"2015","unstructured":"Stringaris A, Vidal-Ribas Belil P, Artiges E, Lemaitre H, Gollier-Briant F, Wolke S et al (2015). The brain\u2019s response to reward anticipation and depression in adolescence: dimensionality, specificity, and longitudinal predictions in a community-based sample. Am J Psychiatry 172: 1215\u20131223.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016143_CR353","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.bbi.2008.01.011","volume":"22","author":"EC Suarez","year":"2008","unstructured":"Suarez EC (2008). Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun 22: 960\u2013968.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2016143_CR354","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1189\/jlb.0210072","volume":"88","author":"T Suganami","year":"2010","unstructured":"Suganami T, Ogawa Y (2010). Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol 88: 33\u201339.","journal-title":"J Leukoc Biol"},{"key":"BFnpp2016143_CR355","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1191\/0269216302pm547xx","volume":"16","author":"Y Sugawara","year":"2002","unstructured":"Sugawara Y, Akechi T, Shima Y, Okuyama T, Akizuki N, Nakano T et al (2002). Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study. Palliat Med 16: 261\u2013263.","journal-title":"Palliat Med"},{"key":"BFnpp2016143_CR356","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.biopsych.2004.10.028","volume":"57","author":"S Surguladze","year":"2005","unstructured":"Surguladze S, Brammer MJ, Keedwell P, Giampietro V, Young AW, Travis MJ et al (2005). A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry 57: 201\u2013209.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR357","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nn.4187","volume":"19","author":"EC Syed","year":"2016","unstructured":"Syed EC, Grima LL, Magill PJ, Bogacz R, Brown P, Walton ME (2016). Action initiation shapes mesolimbic dopamine encoding of future rewards. Nat Neurosci 19: 34\u201336.","journal-title":"Nat Neurosci"},{"key":"BFnpp2016143_CR358","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/1742-2094-9-275","volume":"9","author":"J Takaki","year":"2012","unstructured":"Takaki J, Fujimori K, Miura M, Suzuki T, Sekino Y, Sato K (2012). L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the 'collusion' hypothesis for increased extracellular L-glutamate concentration in neuroinflammation. J Neuroinflammation 9: 275.","journal-title":"J Neuroinflammation"},{"key":"BFnpp2016143_CR359","first-page":"40","volume":"8","author":"SD Targum","year":"2011","unstructured":"Targum SD, Fava M (2011). Fatigue as a residual symptom of depression. Innov Clin Neurosci 8: 40\u201343.","journal-title":"Innov Clin Neurosci"},{"key":"BFnpp2016143_CR360","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11064-005-2678-0","volume":"30","author":"RG Tavares","year":"2005","unstructured":"Tavares RG, Schmidt AP, Abud J, Tasca CI, Souza DO (2005). In vivo quinolinic acid increases synaptosomal glutamate release in rats: reversal by guanosine. Neurochem Res 30: 439\u2013444.","journal-title":"Neurochem Res"},{"key":"BFnpp2016143_CR361","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","volume":"40","author":"RG Tavares","year":"2002","unstructured":"Tavares RG, Tasca CI, Santos CES, Alves LB, Porciuncula LO, Emanuelli T et al (2002). Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem Int 40: 621\u2013627.","journal-title":"Neurochem Int"},{"issue":"1 Suppl 1","key":"BFnpp2016143_CR362","first-page":"23","volume":"25","author":"JL Taylor","year":"1998","unstructured":"Taylor JL, Grossberg SE (1998). The effects of interferon-alpha on the production and action of other cytokines. Semin Oncol 25 (1 Suppl 1): 23\u201329.","journal-title":"Semin Oncol"},{"key":"BFnpp2016143_CR363","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.lfs.2006.09.010","volume":"80","author":"YY Tian","year":"2006","unstructured":"Tian YY, An LJ, Jiang L, Duan YL, Chen J, Jiang B (2006). Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures. Life Sci 80: 193\u2013199.","journal-title":"Life Sci"},{"key":"BFnpp2016143_CR364","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/jnr.21325","volume":"85","author":"S Tilleux","year":"2007","unstructured":"Tilleux S, Hermans E (2007). Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res 85: 2059\u20132070.","journal-title":"J Neurosci Res"},{"key":"BFnpp2016143_CR365","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/ijo.2010.137","volume":"35","author":"NJ Timpson","year":"2011","unstructured":"Timpson NJ, Nordestgaard BG, Harbord RM, Zacho J, Frayling TM, Tybjaerg-Hansen A et al (2011). C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes (Lond) 35: 300\u2013308.","journal-title":"Int J Obes (Lond)"},{"key":"BFnpp2016143_CR366","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbi.2014.05.007","volume":"42","author":"SG Torres-Platas","year":"2014","unstructured":"Torres-Platas SG, Cruceanu C, Chen GG, Turecki G, Mechawar N (2014). Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav Immun 42: 50\u201359.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2016143_CR367","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1037\/a0028813","volume":"121","author":"MT Treadway","year":"2012","unstructured":"Treadway MT, Bossaller NA, Shelton RC, Zald DH (2012a). Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia. J Abnorm Psychol 121: 553.","journal-title":"J Abnorm Psychol"},{"key":"BFnpp2016143_CR368","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1523\/JNEUROSCI.6459-11.2012","volume":"32","author":"MT Treadway","year":"2012","unstructured":"Treadway MT, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS et al (2012b). Dopaminergic mechanisms of individual differences in human effort-based decision-making. J Neurosci 32: 6170\u20136176.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR369","doi-asserted-by":"publisher","first-page":"e6598","DOI":"10.1371\/journal.pone.0006598","volume":"4","author":"MT Treadway","year":"2009","unstructured":"Treadway MT, Buckholtz JW, Schwartzman AN, Lambert WE, Zald DH (2009). Worth the 'EEfRT'? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS One 4: e6598.","journal-title":"PLoS One"},{"key":"BFnpp2016143_CR370","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2045-5380-4-5","volume":"4","author":"MT Treadway","year":"2014","unstructured":"Treadway MT, Pizzagalli DA (2014). Imaging the pathophysiology of major depressive disorder - from localist models to circuit-based analysis. Biol Mood Anxiety Disord 4: 5.","journal-title":"Biol Mood Anxiety Disord"},{"key":"BFnpp2016143_CR371","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.neubiorev.2010.06.006","volume":"35","author":"MT Treadway","year":"2011","unstructured":"Treadway MT, Zald DH (2011). Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev 35: 537\u2013555.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2016143_CR372","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/0963721412474460","volume":"22","author":"MT Treadway","year":"2013","unstructured":"Treadway MT, Zald DH (2013). Parsing anhedonia translational models of reward-processing deficits in psychopathology. Curr Dir Psychol Sci 22: 244\u2013249.","journal-title":"Curr Dir Psychol Sci"},{"key":"BFnpp2016143_CR373","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jpeds.2008.11.040","volume":"154","author":"FK Trefz","year":"2009","unstructured":"Trefz FK, Burton BK, Longo N, Casanova MM, Gruskin DJ, Dorenbaum A et al (2009). Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study. J Pediatr 154: 700\u2013707.","journal-title":"J Pediatr"},{"key":"BFnpp2016143_CR374","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/archpsyc.59.5.409","volume":"59","author":"LK Tremblay","year":"2002","unstructured":"Tremblay LK, Naranjo CA, Cardenas L, Herrmann N, Busto UE (2002). Probing brain reward system function in major depressive disorder: altered response to dextroamphetamine. Arch Gen Psychiatry 59: 409\u2013416.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2016143_CR375","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/archpsyc.62.11.1228","volume":"62","author":"LK Tremblay","year":"2005","unstructured":"Tremblay LK, Naranjo CA, Graham SJ, Herrmann N, Mayberg HS, Hevenor S et al (2005). Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 62: 1228\u20131236.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2016143_CR376","doi-asserted-by":"publisher","first-page":"16064","DOI":"10.1523\/JNEUROSCI.4158-11.2011","volume":"31","author":"ME Tremblay","year":"2011","unstructured":"Tremblay ME, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A (2011). The role of microglia in the healthy brain. J Neurosci 31: 16064\u201316069.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR377","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4088\/JCP.v69n0211","volume":"69","author":"MH Trivedi","year":"2008","unstructured":"Trivedi MH, Hollander E, Nutt D, Blier P (2008). Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression. J Clin Psychiatry 69: 246\u2013258.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2016143_CR378","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1046\/j.1471-4159.1998.70010260.x","volume":"70","author":"M Uomoto","year":"1998","unstructured":"Uomoto M, Nishibori M, Nakaya N, Takeuchi Y, Iwagaki H, Tanaka N et al (1998). Changes in monoamine turnover in the brain of cachectic mice bearing colon-26 tumor cells. J Neurochem 70: 260\u2013267.","journal-title":"J Neurochem"},{"key":"BFnpp2016143_CR379","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ymgme.2011.10.014","volume":"105","author":"JR Utz","year":"2012","unstructured":"Utz JR, Lorentz CP, Markowitz D, Rudser KD, Diethelm-Okita B, Erickson D et al (2012). START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients. Mol Genet Metab 105: 193\u2013197.","journal-title":"Mol Genet Metab"},{"key":"BFnpp2016143_CR380","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejphar.2014.01.014","volume":"725","author":"F van Heesch","year":"2014","unstructured":"van Heesch F, Prins J, Konsman JP, Korte-Bouws GA, Westphal KG, Rybka J et al (2014). Lipopolysaccharide increases degradation of central monoamines: an in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice. Eur J Pharmacol 725: 55\u201363.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2016143_CR381","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bbi.2012.12.013","volume":"29","author":"F van Heesch","year":"2013","unstructured":"van Heesch F, Prins J, Konsman JP, Westphal KG, Olivier B, Kraneveld AD et al (2013). Lipopolysaccharide-induced anhedonia is abolished in male serotonin transporter knockout rats: an intracranial self-stimulation study. Brain Behav Immun 29: 98\u2013103.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2016143_CR382","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1523\/JNEUROSCI.0454-15.2015","volume":"35","author":"C Varazzani","year":"2015","unstructured":"Varazzani C, San-Galli A, Gilardeau S, Bouret S (2015). Noradrenaline and dopamine neurons in the reward\/effort trade-off: a direct electrophysiological comparison in behaving monkeys. J Neurosci 35: 7866\u20137877.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR383","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1111\/j.1471-4159.2007.04690.x","volume":"102","author":"S Venneti","year":"2007","unstructured":"Venneti S, Lopresti BJ, Wang G, Slagel SL, Mason NS, Mathis CA et al (2007). A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation. J Neurochem 102: 2118\u20132131.","journal-title":"J Neurochem"},{"key":"BFnpp2016143_CR384","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1038\/npp.2011.135","volume":"36","author":"VV Venugopalan","year":"2011","unstructured":"Venugopalan VV, Casey KF, O'Hara C, O'Loughlin J, Benkelfat C, Fellows LK et al (2011). Acute phenylalanine\/tyrosine depletion reduces motivation to smoke cigarettes across stages of addiction. Neuropsychopharmacology 36: 2469\u20132476.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR385","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1210\/jcem.84.8.5894","volume":"84","author":"AN Vgontzas","year":"1999","unstructured":"Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A et al (1999). Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84: 2603\u20132607.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFnpp2016143_CR386","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1210\/jc.2003-031562","volume":"89","author":"AN Vgontzas","year":"2004","unstructured":"Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A et al (2004). Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 89: 2119\u20132126.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFnpp2016143_CR387","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1038\/npp.2014.141","volume":"39","author":"EG Vichaya","year":"2014","unstructured":"Vichaya EG, Hunt SC, Dantzer R (2014). Lipopolysaccharide reduces incentive motivation while boosting preference for high reward in mice. Neuropsychopharmacology 39: 2884\u20132890.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR388","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/npp.2014.242","volume":"40","author":"V Voon","year":"2015","unstructured":"Voon V, Morris LS, Irvine MA, Ruck C, Worbe Y, Derbyshire K et al (2015). Risk-taking in disorders of natural and drug rewards: neural correlates and effects of probability, valence, and magnitude. Neuropsychopharmacology 40: 804\u2013812.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR389","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00702-014-1313-0","volume":"122","author":"U Walter","year":"2015","unstructured":"Walter U, Heilmann R, Kaulitz L, Just T, Krause BJ, Benecke R et al (2015). Prediction of Parkinson's disease subsequent to severe depression: a ten-year follow-up study. J Neural Transm (Vienna) 122: 789\u2013797.","journal-title":"J Neural Transm (Vienna)"},{"key":"BFnpp2016143_CR390","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/sj.mp.4002013","volume":"13","author":"J Wang","year":"2008","unstructured":"Wang J, Campbell IL, Zhang H (2008). Systemic interferon-alpha regulates interferon-stimulated genes in the central nervous system. Mol Psychiatry 13: 293\u2013301.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016143_CR391","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.neulet.2005.12.046","volume":"397","author":"JY Wang","year":"2006","unstructured":"Wang JY, Zeng XY, Fan GX, Yuan YK, Tang JS (2006). mu- but not delta- and kappa-opioid receptor mediates the nucleus submedius interferon-alpha-evoked antinociception in the rat. Neurosci Lett 397: 254\u2013258.","journal-title":"Neurosci Lett"},{"key":"BFnpp2016143_CR392","doi-asserted-by":"publisher","first-page":"16597","DOI":"10.1523\/JNEUROSCI.4387-11.2011","volume":"31","author":"MC Wardle","year":"2011","unstructured":"Wardle MC, Treadway MT, Mayo LM, Zald DH, de Wit H (2011). Amping up effort: effects of d-amphetamine on human effort-based decision-making. J Neurosci 31: 16597\u201316602.","journal-title":"J Neurosci"},{"key":"BFnpp2016143_CR393","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0304-3940(94)11105-R","volume":"183","author":"LR Watkins","year":"1995","unstructured":"Watkins LR, Goehler LE, Relton JK, Tartaglia N, Silbert L, Martin D et al (1995). Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett 183: 27\u201331.","journal-title":"Neurosci Lett"},{"key":"BFnpp2016143_CR394","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0006-8993(94)91742-6","volume":"639","author":"LR Watkins","year":"1994","unstructured":"Watkins LR, Wiertelak EP, Goehler LE, Mooney-Heiberger K, Martinez J, Furness L et al (1994). Neurocircuitry of illness-induced hyperalgesia. Brain Res 639: 283\u2013299.","journal-title":"Brain Res"},{"key":"BFnpp2016143_CR395","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796\u20131808.","journal-title":"J Clin Invest"},{"key":"BFnpp2016143_CR396","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/23148","volume":"400","author":"T Wichmann","year":"1999","unstructured":"Wichmann T, DeLong MR (1999). Oscillations in the basal ganglia. Nature 400: 621\u2013622.","journal-title":"Nature"},{"key":"BFnpp2016143_CR397","first-page":"9","volume":"91","author":"T Wichmann","year":"2003","unstructured":"Wichmann T, DeLong MR (2003). Functional neuroanatomy of the basal ganglia in Parkinson's disease. Adv Neurol 91: 9\u201318.","journal-title":"Adv Neurol"},{"key":"BFnpp2016143_CR398","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.schres.2013.10.017","volume":"151","author":"LE Williams","year":"2013","unstructured":"Williams LE, Blackford JU, Luksik A, Gauthier I, Heckers S (2013). Reduced habituation in patients with schizophrenia. Schizophr Res 151: 124\u2013132.","journal-title":"Schizophr Res"},{"key":"BFnpp2016143_CR399","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nucmedbio.2007.12.009","volume":"35","author":"AA Wilson","year":"2008","unstructured":"Wilson AA, Garcia A, Parkes J, McCormick P, Stephenson KA, Houle S et al (2008). Radiosynthesis and initial evaluation of [18 F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. Nucl Med Biol 35: 305\u2013314.","journal-title":"Nucl Med Biol"},{"key":"BFnpp2016143_CR400","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.tins.2013.11.003","volume":"37","author":"TT Winton-Brown","year":"2014","unstructured":"Winton-Brown TT, Fusar-Poli P, Ungless MA, Howes OD (2014). Dopaminergic basis of salience dysregulation in psychosis. Trends Neurosci 37: 85\u201394.","journal-title":"Trends Neurosci"},{"key":"BFnpp2016143_CR401","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.psyneuen.2012.02.003","volume":"37","author":"ES Wohleb","year":"2012","unstructured":"Wohleb ES, Fenn AM, Pacenta AM, Powell ND, Sheridan JF, Godbout JP (2012). Peripheral innate immune challenge exaggerated microglia activation, increased the number of inflammatory CNS macrophages, and prolonged social withdrawal in socially defeated mice. Psychoneuroendocrinology 37: 1491\u20131505.","journal-title":"Psychoneuroendocrinology"},{"key":"BFnpp2016143_CR402","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.biopsych.2013.11.029","volume":"75","author":"ES Wohleb","year":"2014","unstructured":"Wohleb ES, McKim DB, Shea DT, Powell ND, Tarr AJ, Sheridan JF et al (2014). Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain. Biol Psychiatry 75: 970\u2013981.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR403","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/schbul\/sbu026","volume":"40","author":"DH Wolf","year":"2014","unstructured":"Wolf DH, Satterthwaite TD, Kantrowitz JJ, Katchmar N, Vandekar L, Elliott MA et al (2014). Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures. Schizophr Bull 40: 1328\u20131337.","journal-title":"Schizophr Bull"},{"key":"BFnpp2016143_CR404","doi-asserted-by":"publisher","first-page":"25804","DOI":"10.1074\/jbc.273.40.25804","volume":"273","author":"Y Xia","year":"1998","unstructured":"Xia Y, Tsai AL, Berka V, Zweier JL (1998). Superoxide generation from endothelial nitric-oxide synthase. A Ca2+\/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 273: 25804\u201325808.","journal-title":"J Biol Chem"},{"key":"BFnpp2016143_CR405","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.lfs.2009.05.016","volume":"85","author":"X Xie","year":"2009","unstructured":"Xie X, Mhaskar Y, Arbogast LA, Trammell RA, Hughes LF, Toth LA (2009). Adenosine receptor antagonists and behavioral activation in NF-kappaB p50 subunit knockout mice. Life Sci 85: 226\u2013234.","journal-title":"Life Sci"},{"key":"BFnpp2016143_CR406","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.biopsych.2014.06.021","volume":"77","author":"JJ Yang","year":"2015","unstructured":"Yang JJ, Wang N, Yang C, Shi JY, Yu HY, Hashimoto K (2015). Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression. Biol Psychiatry 77: e19\u2013e20.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016143_CR407","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.psychres.2014.08.056","volume":"220","author":"X-h Yang","year":"2014","unstructured":"Yang X-h, Huang J, Zhu C-y, Wang Y-f, Cheung EFC, Chan RCK et al (2014). Motivational deficits in effort-based decision making in individuals with subsyndromal depression, first-episode and remitted depression patients. Psychiatry Res 220: 874\u2013882.","journal-title":"Psychiatry Res"},{"key":"BFnpp2016143_CR408","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ptr.5247","volume":"29","author":"KY Yeh","year":"2015","unstructured":"Yeh KY, Shou SS, Lin YX, Chen CC, Chiang CY, Yeh CY (2015). Effect of Ginkgo biloba extract on lipopolysaccharide-induced anhedonic depressive-like behavior in male rats. Phytother Res 29: 260\u2013266.","journal-title":"Phytother Res"},{"key":"BFnpp2016143_CR409","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1749-6632.2000.tb05412.x","volume":"917","author":"R Yirmiya","year":"2000","unstructured":"Yirmiya R, Pollak Y, Morag M, Reichenberg A, Barak O, Avitsur R et al (2000). Illness, cytokines, and depression. Ann NY Acad Sci 917: 478\u2013487.","journal-title":"Ann NY Acad Sci"},{"key":"BFnpp2016143_CR410","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-0-585-37970-8_16","volume":"461","author":"R Yirmiya","year":"1999","unstructured":"Yirmiya R, Weidenfeld J, Pollak Y, Morag M, Morag A, Avitsur R et al (1999). Cytokines, \"depression due to a general medical condition,\" and antidepressant drugs. Adv Exp Med Biol 461: 283\u2013316.","journal-title":"Adv Exp Med Biol"},{"key":"BFnpp2016143_CR411","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00213-015-4176-7","volume":"233","author":"SE Yohn","year":"2016","unstructured":"Yohn SE, Lopez-Cruz L, Hutson PH, Correa M, Salamone JD (2016). Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat. Psychopharmacology (Berl) 233: 949\u2013960.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2016143_CR412","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00213-014-3766-0","volume":"232","author":"SE Yohn","year":"2015","unstructured":"Yohn SE, Thompson C, Randall PA, Lee CA, Muller CE, Baqi Y et al (2015). The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology (Berl) 232: 1313\u20131323.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2016143_CR413","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/ndt\/17.6.1032","volume":"17","author":"K Yokoyama","year":"2002","unstructured":"Yokoyama K, Tajima M, Yoshida H, Nakayama M, Tokutome G, Sakagami H et al (2002). Plasma pteridine concentrations in patients with chronic renal failure. Nephrol Dial Transplant 17: 1032\u20131036.","journal-title":"Nephrol Dial Transplant"},{"key":"BFnpp2016143_CR414","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1126\/science.1167342","volume":"323","author":"KA Zaghloul","year":"2009","unstructured":"Zaghloul KA, Blanco JA, Weidemann CT, McGill K, Jaggi JL, Baltuch GH et al (2009). Human substantia nigra neurons encode unexpected financial rewards. Science 323: 1496\u20131499.","journal-title":"Science"},{"key":"BFnpp2016143_CR415","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.stemcr.2014.05.015","volume":"3","author":"LS Zheng","year":"2014","unstructured":"Zheng LS, Hitoshi S, Kaneko N, Takao K, Miyakawa T, Tanaka Y et al (2014). Mechanisms for interferon-alpha-induced depression and neural stem cell dysfunction. Stem Cell Rep 3: 73\u201384.","journal-title":"Stem Cell Rep"},{"key":"BFnpp2016143_CR416","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/sj.npp.1301029","volume":"31","author":"CB Zhu","year":"2006","unstructured":"Zhu CB, Blakely RD, Hewlett WA (2006). The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31: 2121\u20132131.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR417","doi-asserted-by":"publisher","first-page":"15649","DOI":"10.1074\/jbc.M410858200","volume":"280","author":"CB Zhu","year":"2005","unstructured":"Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD (2005). p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem 280: 15649\u201315658.","journal-title":"J Biol Chem"},{"key":"BFnpp2016143_CR418","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1038\/npp.2010.116","volume":"35","author":"CB Zhu","year":"2010","unstructured":"Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA (2010). Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 35: 2510\u20132520.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016143_CR419","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1089\/jir.2011.0093","volume":"32","author":"H Zoller","year":"2012","unstructured":"Zoller H, Schloegl A, Schroecksnadel S, Vogel W, Fuchs D (2012). Interferon-alpha therapy in patients with hepatitis C virus infection increases plasma phenylalanine and the phenylalanine to tyrosine ratio. J Interferon Cytokine Res 32: 216\u2013220.","journal-title":"J Interferon Cytokine Res"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/npp2016143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npp2016143","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npp2016143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T02:05:39Z","timestamp":1650333939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2016143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,2]]},"references-count":419,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFnpp2016143"],"URL":"https:\/\/doi.org\/10.1038\/npp.2016.143","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,2]]},"assertion":[{"value":"7 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}